{
  "meta": {
    "title": "00040_Late_Night_Pyq_Pyt_Marathon_-_40",
    "url": "https://brainandscalpel.vercel.app/00040-late-night-pyq-pyt-marathon-40-bc9e5ffe.html",
    "scrapedAt": "2025-11-29T17:24:49.820Z"
  },
  "questions": [
    {
      "id": 11678,
      "choices": [
        {
          "id": 46678,
          "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12.0pt;\">Dysphagia</span></p>"
        },
        {
          "id": 46679,
          "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12.0pt;\">Spasticity</span></p>"
        },
        {
          "id": 46680,
          "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12.0pt;\">Fever</span></p>"
        },
        {
          "id": 46681,
          "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12.0pt;\">Neglect</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following features of stroke need not be treated? (AIIMS NOV 2017)</span></p>",
      "unique_key": "Q5716399",
      "question_audio": null,
      "question_video": null,
      "map_id": 13063871,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Neglect</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neglect after a stroke, often presenting as a lack of awareness of one side of the body, does not typically require direct medical treatment. While it may indicate a more severe stroke and can impact rehabilitation, many patients improve as they recover from other stroke symptoms. Therapy focuses on aiding patients in adapting to or compensating for this deficit.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Dysphagia:</strong> Must be treated to prevent complications like aspiration pneumonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Spasticity:</strong> Requires management with medications (baclofen, tizanidine) or physical therapy to improve mobility and reduce discomfort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fever:</strong> Should be treated promptly as it can exacerbate brain injury and worsen outcomes in stroke patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While neglect is a common symptom following a stroke, it does not typically require specific medical treatment but rather supportive care and rehabilitation to help the patient adapt. Other physical symptoms such as dysphagia, spasticity, and fever require active medical management to prevent complications.</span></p>",
      "correct_choice_id": 46681,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20937,
      "choices": [
        {
          "id": 83712,
          "text": "<p><span style=\"font-size:12.0pt;\">Hexosaminidase A</span></p>"
        },
        {
          "id": 83713,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocerebrosidase</span></p>"
        },
        {
          "id": 83714,
          "text": "<p><span style=\"font-size:12.0pt;\">Sphingomyelinase</span></p>"
        },
        {
          "id": 83715,
          "text": "<p><span style=\"font-size:12.0pt;\">α-1,4-Glucosidase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with bone pain and hepatosplenomegaly. A trephine biopsy and aspirate show the following finding. Which of the following is the most likely enzyme deficient in this condition?(NEET &nbsp;PG 2023)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/08/picture22.jpg\" alt=\"\" width=\"300\" height=\"224\"></span></p>",
      "unique_key": "Q6581930",
      "question_audio": null,
      "question_video": null,
      "map_id": 13063872,
      "difficulty_level": "beginner",
      "subjects_id": [
        1
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Glucocerebrosidase</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical vignette of a child with bone pain, hepatosplenomegaly, and trephine biopsy showing a cell with a characteristic crumpled tissue paper appearance points to diagnosis of Gaucher's disease, in which enzyme deficient is glucocerebrosidase (also known as beta-glucosidase).</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-29%20134931.jpg\" width=\"1068\" height=\"764\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Gaucher’s Disease</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-05-29%20135020.jpg\" width=\"866\" height=\"560\"></p>",
      "correct_choice_id": 83713,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54681,
      "choices": [
        {
          "id": 218189,
          "text": "<p><span style=\"font-size:12.0pt;\">Sevoflurane</span></p>"
        },
        {
          "id": 218190,
          "text": "<p><span style=\"font-size:12.0pt;\">Desflurane</span></p>"
        },
        {
          "id": 218191,
          "text": "<p><span style=\"font-size:12.0pt;\">Isoflurane</span></p>"
        },
        {
          "id": 218192,
          "text": "<p><span style=\"font-size:12.0pt;\">Halothane</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which inhaled anesthetic agent is preferred for pediatric induction of anesthesia? (INICET MAY 2024)</span></p>",
      "unique_key": "Q9833953",
      "question_audio": null,
      "question_video": null,
      "map_id": 13063873,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) Sevoflurane</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sevoflurane is the preferred inhaled anesthetic agent for the induction of anesthesia in pediatric patients. This is primarily due to its pleasant, sweet smell, which makes it more tolerable for children to inhale. Additionally, Sevoflurane has a rapid onset of action, meaning it works quickly to induce anesthesia. This quick induction is critical in pediatric patients who often do not have an intravenous (IV) line placed before induction. The ability to induce anesthesia effectively and without distress is a significant advantage in this age group.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Desflurane:</strong> Desflurane is not preferred for pediatric induction because it has a pungent odor, which can be irritating and unpleasant for children. Moreover, it can cause airway irritation, which is undesirable during induction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Isoflurane:</strong> While Isoflurane is effective as an anesthetic, it also has a pungent smell and slower onset of action compared to Sevoflurane, making it less ideal for pediatric use.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Halothane:</strong> Halothane was previously used for pediatric induction, but it has largely fallen out of favor due to its potential for causing liver toxicity and its slower onset of action compared to Sevoflurane.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Sevoflurane is the anesthetic agent of choice for inhalational induction in pediatric patients due to its sweet smell and rapid onset of action.</span></p>",
      "correct_choice_id": 218189,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7011,
      "choices": [
        {
          "id": 28012,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Griseofulvin</span></span></span></p>"
        },
        {
          "id": 28013,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amphotericin B</span></span></span></p>"
        },
        {
          "id": 28014,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ampicillin</span></span></span></p>"
        },
        {
          "id": 28015,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aspirin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For which of the following drugs, absorption is increased after a fatty meal? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q7211663",
      "question_audio": null,
      "question_video": null,
      "map_id": 13063874,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Griseofulvin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Griseofulvin is an antifungal drug that acts by blocking the microtubules. It is given orally, preferably with a fatty meal, which has been found to increase its absorption. This enhancement in absorption is due to the lipophilic nature of griseofulvin, which allows it to dissolve better in the presence of dietary fats, facilitating its uptake in the gastrointestinal tract.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B.</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amphotericin B</span></strong>: Amphotericin B is an antifungal medication primarily administered intravenously due to poor oral absorption. Its absorption is not significantly affected by meals.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">C. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ampicillin</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Ampicillin is an antibiotic that is generally well absorbed on an empty stomach. Food can actually reduce the absorption of ampicillin.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option </span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">D. <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Aspirin</span></strong></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Aspirin is an anti-inflammatory and antipyretic drug. Its absorption is not significantly increased by fatty meals, although taking it with food can help minimize gastrointestinal side effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drugs whose absorption increase with meals</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Griseofulvin</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Statins</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Halofantrine</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erlotinib</span></span></span></p>",
      "correct_choice_id": 28012,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11366,
      "choices": [
        {
          "id": 45430,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Megacolon</span></span></span></p>"
        },
        {
          "id": 45431,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Parathyroid adenoma</span></span></span></p>"
        },
        {
          "id": 45432,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mucosal neuroma</span></span></span></p>"
        },
        {
          "id": 45433,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Marfanoid habitus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is not seen in MEN 2B syndrome? (Neet pg 2022)</span></span></span></p>",
      "unique_key": "Q5594578",
      "question_audio": null,
      "question_video": null,
      "map_id": 13063875,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Parathyroid adenoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Parathyroid adenomas</span></strong><span style=\"font-size:12.0pt\"> are not seen in MEN 2B. Parathyroid adenomas are typically associated with MEN 1 and MEN 2A syndromes, where hyperparathyroidism is a common feature due to the involvement of the parathyroid glands.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Multiple Endocrine Neoplasia type 2B (MEN 2B) is a genetic syndrome characterized by specific clinical features. It is also known as the &quot;<strong>Triple M syndrome</strong>&quot; because it typically presents with the following:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Mucosal Neuromas:</span></strong><span style=\"font-size:12.0pt\"> These are benign growths on the mucous membranes and are a hallmark of MEN 2B.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Marfanoid Habitus:</span></strong><span style=\"font-size:12.0pt\"> This refers to a body habitus resembling Marfan syndrome, with features like long limbs, a tall, slender build, and hyperflexible joints.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Medullary Thyroid Carcinoma (MTC):</span></strong><span style=\"font-size:12.0pt\"> This is a type of thyroid cancer commonly associated with MEN 2B.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Other features that can be seen in MEN 2B include pheochromocytomas (tumors of the adrenal glands) and ganglioneuromas (tumors of the nerve cells).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Megacolon:&nbsp;</strong>Megacolon can be associated with MEN 2B due to the presence of ganglioneuromatosis affecting the gastrointestinal tract.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Mucosal Neuroma:&nbsp;</strong>As mentioned, mucosal neuromas are a classic feature of MEN 2B and one of the reasons it is called &quot;triple M syndrome.&quot;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Marfanoid Habitus:&nbsp;</strong>This characteristic physical appearance is commonly seen in MEN 2B patients.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MEN 2B syndrome, also known as &quot;triple M syndrome,&quot; is characterized by mucosal neuromas, marfanoid habitus, and medullary thyroid carcinoma, but does not involve parathyroid adenomas.</span></span></span></p>",
      "correct_choice_id": 45431,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24749,
      "choices": [
        {
          "id": 98957,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Point mutation</span></span></span></p>"
        },
        {
          "id": 98958,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Deletion of gene</span></span></span></p>"
        },
        {
          "id": 98959,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Translocation</span></span></span></p>"
        },
        {
          "id": 98960,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inversion</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A case of complete gonadal dysgenesis was observed in a 46XY individual with female characteristics. The origin of complete gonadal dysgenesis lies in alterations of the SRY gene. What leads to complete gonadal dysgenesis in the SRY gene?</span></span> <span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2023)</span></span></p>",
      "unique_key": "Q7278587",
      "question_audio": null,
      "question_video": null,
      "map_id": 13063877,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Deletion of gene </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Complete gonadal dysgenesis in a 46XY individual is typically associated with alterations in the SRY gene, which is crucial for initiating male sex determination. The SRY gene, located on the Y chromosome, directs the development of the gonads into testes. When this gene is deleted, it results in a failure to initiate testis formation, leading to a phenotypically female individual with a 46XY karyotype. In 10-15% of cases of 46XY gonadal dysgenesis, the SRY gene deletion is the underlying cause. This leads to a failure in developing male characteristics and results in complete gonadal dysgenesis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Point mutation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Point mutations in the SRY gene can also lead to gonadal dysgenesis, but this accounts for only a small percentage of cases. The mutations typically involve changes in the DNA sequence that alter the function of the SRY protein but do not necessarily delete the gene.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Translocation</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Translocation refers to the movement of the SRY gene to another chromosome, which can sometimes lead to sex reversal if the SRY gene is present on an X chromosome in a 46XX individual. However, this is not the primary mechanism for complete gonadal dysgenesis in a 46XY individual.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Inversion</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Inversions involve a segment of the chromosome being reversed end to end. This type of chromosomal rearrangement is less commonly associated with gonadal dysgenesis and is not a typical cause of the condition.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Complete gonadal dysgenesis in a 46XY individual is primarily caused by the deletion of the SRY gene, which leads to a failure in the development of male gonads, resulting in female characteristics.</span></span></span></p>",
      "correct_choice_id": 98958,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11468,
      "choices": [
        {
          "id": 45838,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased schistocytes</span></p>"
        },
        {
          "id": 45839,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased PT</span></p>"
        },
        {
          "id": 45840,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased fibrinogen</span></p>"
        },
        {
          "id": 45841,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased FDPs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which among the following is wrong about DIC? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q4165526",
      "question_audio": null,
      "question_video": null,
      "map_id": 13063878,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Increased fibrinogen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Disseminated Intravascular Coagulation (DIC) is a complex condition characterized by systemic activation of blood clotting, which results in the generation and deposition of fibrin, leading to microvascular thrombi in various organs and contributing to multiple organ dysfunction syndrome. As a part of this process, there is widespread consumption of clotting factors and platelets, which leads to a paradoxical increase in bleeding risk.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Increased fibrinogen&nbsp;</strong>is incorrect because in DIC, fibrinogen is typically decreased, not increased. This decrease is due to its consumption during the formation of fibrin clots throughout the body.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>30% of patients w/DIC may have schistocytes on PS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>Consumption of clotting factors leads to ↑PT, aPTT. Presence of normal PT, aPTT w/schistocytes hints towards possibility of MAHA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>FDP are elevated due to activation of coagulation cascade.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In DIC, one typically sees a constellation of laboratory findings including decreased fibrinogen, increased PT and aPTT, elevated FDPs, and the presence of schistocytes on peripheral blood smear. These changes reflect both the excessive activation of the coagulation cascade and the secondary activation of fibrinolytic pathways, leading to the consumption of clotting factors and secondary bleeding complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Hematology/Coagulation disorders</strong></span></p>",
      "correct_choice_id": 45840,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43258,
      "choices": [
        {
          "id": 172699,
          "text": "<p><span style=\"font-size:12pt;\">25%</span></p>"
        },
        {
          "id": 172700,
          "text": "<p><span style=\"font-size:12pt;\">&nbsp;30%</span></p>"
        },
        {
          "id": 172701,
          "text": "<p><span style=\"font-size:12pt;\">&nbsp;40%</span></p>"
        },
        {
          "id": 172702,
          "text": "<p><span style=\"font-size:12pt;\">&nbsp;45%</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A child was being delivered oxygen by nasal canula at 3L/min. What is the FiO2 being delivered?</span><span style=\"font-size:12.0pt;\">&nbsp;</span>&nbsp;(INICET NOVEMBER 2023)</p>",
      "unique_key": "Q8086256",
      "question_audio": null,
      "question_video": null,
      "map_id": 13063879,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B.&nbsp; 30%</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The fraction of inspired oxygen (FiO2) delivered by nasal cannula increases by approximately 4% for every 1 liter per minute of oxygen flow. Thus:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">1 L/min would raise the FiO2 to about 24%.</span></li><li><span style=\"font-size:12pt;\">2 L/min would be about 28%.</span></li><li><span style=\"font-size:12pt;\">3 L/min would be about 32%.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Given the options provided, the closest and most commonly accepted approximation for the FiO2 being delivered at a flow rate of 3 L/min through a nasal cannula would be around 30%.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;A. 25%:</strong> This FiO2 would typically correspond to an oxygen flow rate of about 1 L/min via nasal cannula.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;C. 40%:</strong> This FiO2 would typically correspond to an oxygen flow rate of about 5 L/min via nasal cannula.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;D. 45%:</strong> This FiO2 would typically correspond to an oxygen flow rate of about 6 L/min via nasal cannula.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The FiO2 delivered by a nasal cannula at a flow rate of 3 L/min is approximately 30%.</span></p>",
      "correct_choice_id": 172700,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7039,
      "choices": [
        {
          "id": 28124,
          "text": "<p><span style=\"font-size:12pt;\">Proguanil</span></p>"
        },
        {
          "id": 28125,
          "text": "<p><span style=\"font-size:12pt;\">Sulindac</span></p>"
        },
        {
          "id": 28126,
          "text": "<p><span style=\"font-size:12pt;\">Primidone</span></p>"
        },
        {
          "id": 28127,
          "text": "<p><span style=\"font-size:12pt;\">5-Fluorouracil</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is not a prodrug? (AIIMS MAY 2020)</span></p>",
      "unique_key": "Q9157458",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064000,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Primidone</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Prodrugs are drugs that are present in their inactive form and are converted to the active form in the body after undergoing metabolism.</span></li><li><span style=\"font-size:12pt;\">Among the given options primidone is not a prodrug. Although it produces active metabolites like phenobarbitone and phenylethylmalonamide (PEMA) but it cannot be considered as a prodrug because primidone itself is also active.</span></li></ul><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong> <strong>A.</strong> <strong>Proguanil:</strong> Proguanil is a prodrug and its active metabolite is cycloguanil. It is used in the treatment and prevention of malaria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong> <strong>C.</strong> <strong>Sulindac</strong>: Sulindac is a sulfoxide prodrug used in inflammatory diseases including osteoarthritis, rheumatoid arthritis, ankylosing spondylitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong> <strong>D. Flurouracil:</strong> Flurouracil&nbsp; is a prodrug having the active metabolite as fluorouridine monophosphate. It is an anticancer chemotherapeutic agent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Primidone is not a prodrug because it is pharmacologically active in its original form, although it also produces active metabolites. Prodrugs like Proguanil, Sulindac, and 5-Fluorouracil require metabolic activation to exert their therapeutic effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Mnemonic</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/18/screenshot-2024-07-18-101615.png\" alt=\"\" width=\"1000\" height=\"418\"></p>",
      "correct_choice_id": 28126,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4489,
      "choices": [
        {
          "id": 17932,
          "text": "<p><span style=\"font-size:12pt;\">EEG</span></p>"
        },
        {
          "id": 17933,
          "text": "<p><span style=\"font-size:12pt;\">Provoked lower esophageal contractility</span></p>"
        },
        {
          "id": 17934,
          "text": "<p><span style=\"font-size:12pt;\">Entropy</span></p>"
        },
        {
          "id": 17935,
          "text": "<p><span style=\"font-size:12pt;\">Bispectral index</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which among the following monitors is most commonly used to monitor the depth of anesthesia?</span></p>",
      "unique_key": "Q4781627",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064001,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Bispectral index</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>The bispectral index</strong> (BIS) is the most commonly used method to monitor the depth of anesthesia and determine the level of consciousness under anesthesia.</span></li><li><span style=\"font-size:12pt;\">BIS is derived from the EEG (electroencephalogram) and shows the cerebral drug effect of an anesthetic drug.</span></li><li><span style=\"font-size:12pt;\">BIS values range from 0-100, where lower values indicate deeper anesthesia.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. EEG:&nbsp;</strong>While EEG is the basis for BIS, it is not typically used directly in clinical practice to monitor anesthesia depth due to its complexity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Provoked lower esophageal contractility:&nbsp;</strong>This is not a standard or common method for monitoring the depth of anesthesia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Entropy:&nbsp;</strong>Entropy monitoring is another EEG-based technique used to assess the depth of anesthesia. However, it is less commonly used compared to BIS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The bispectral index (BIS) is the most commonly used monitor to assess the depth of anesthesia, providing an EEG-derived measure of the cerebral effects of anesthetic drugs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/picture70_8iI3h7S.jpg\" alt=\"\" width=\"1000\" height=\"207\"></span></p>",
      "correct_choice_id": 17935,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InstrumentsBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10072,
      "choices": [
        {
          "id": 40254,
          "text": "<p><span style=\"font-size:12.0pt;\">Cervical carcinoma</span></p>"
        },
        {
          "id": 40255,
          "text": "<p><span style=\"font-size:12.0pt;\">Anal carcinoma</span></p>"
        },
        {
          "id": 40256,
          "text": "<p><span style=\"font-size:12.0pt;\">Oropharyngeal carcinoma</span></p>"
        },
        {
          "id": 40257,
          "text": "<p><span style=\"font-size:12.0pt;\">Laryngeal papillomatosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following conditions are caused by high-risk strains of Human Papilloma virus except:</span> <span style=\"font-size:12.0pt;\">(INICET MAY 2022)</span></p>",
      "unique_key": "Q2607942",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064002,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Laryngeal papillomatosis</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/10/screenshot-2023-11-10-120647.jpg\" alt=\"\" width=\"1000\" height=\"387\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Laryngeal papillomatosis is not caused by high-risk HPV strains but by low-risk HPV strains (6 and 11).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cervical carcinoma:</strong> Caused by high-risk HPV strains, particularly HPV 16 and 18.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anal carcinoma:</strong> Also associated with high-risk HPV strains, including HPV 16.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Oropharyngeal carcinoma:</strong> Linked to high-risk HPV strains, notably HPV 16.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Laryngeal papillomatosis is caused by low-risk HPV strains (6 and 11) and not by the high-risk strains associated with cancers such as cervical, anal, and oropharyngeal carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins pathologic basis of disease 8th edition pg 563</strong></span></p>",
      "correct_choice_id": 40257,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3675,
      "choices": [
        {
          "id": 14679,
          "text": "<p><span style=\"font-size:12.0pt;\">Seminiferous tubule</span></p>"
        },
        {
          "id": 14680,
          "text": "<p><span style=\"font-size:12.0pt;\">Area postrema</span></p>"
        },
        {
          "id": 14681,
          "text": "<p><span style=\"font-size:12.0pt;\">Optic nerve</span></p>"
        },
        {
          "id": 14682,
          "text": "<p><span style=\"font-size:12.0pt;\">Loop of Henle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an immunologically privileged site?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">NOV 2018)</span></p>",
      "unique_key": "Q7639501",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064003,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Seminiferous tubule</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The seminiferous tubules are an immunologically privileged site.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Sites with immune privilege are anatomical regions that are naturally less subject to immune responses than most other areas of the body. So, an allograft can be placed in these sites without endangering a rejection reaction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other examples:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Anterior chamber of the eye</span></li><li><span style=\"font-size:12.0pt;\">Cornea</span></li><li><span style=\"font-size:12.0pt;\">Testes</span></li><li><span style=\"font-size:12.0pt;\">Brain except at area postrema where blood brain barrier is absent</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Area postrema:</strong> This region of the brain lacks the blood-brain barrier and is not considered an immunologically privileged site.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Optic nerve:</strong> While the optic nerve is part of the central nervous system, it is not classified as an immunologically privileged site like the brain or anterior chamber of the eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Loop of Henle:</strong> This structure is part of the kidney's nephron and is not considered an immunologically privileged site.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The seminiferous tubules are an immunologically privileged site, protecting developing sperm from immune system attack.</span></p>",
      "correct_choice_id": 14679,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10026,
      "choices": [
        {
          "id": 40070,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelet</span></p>"
        },
        {
          "id": 40071,
          "text": "<p><span style=\"font-size:12.0pt;\">Intrinsic</span></p>"
        },
        {
          "id": 40072,
          "text": "<p><span style=\"font-size:12.0pt;\">Extrinsic</span></p>"
        },
        {
          "id": 40073,
          "text": "<p><span style=\"font-size:12.0pt;\">vWD</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following represents maximum amplitude in Thromboelastography? (INICET NOV 2022)</span></p>",
      "unique_key": "Q4995419",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064004,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Platelet</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Thromboelastography (TEG) is a test that measures the viscoelastic properties of blood as it clots under low shear conditions, mimicking sluggish venous flow. The <strong>maximum amplitude (MA)</strong> on a TEG tracing represents the final strength of the clot and is predominantly determined by the number and function of platelets and fibrin interaction.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Platelets</strong> play a crucial role in forming the solid clot structure, which is reflected by the MA. Thus, the maximum amplitude in TEG is directly associated with platelet function and quantity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture3.jpg\" alt=\"\" width=\"250\" height=\"419\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture4.jpg\" alt=\"\" width=\"500\" height=\"225\"></span></p><p>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Intrinsic and&nbsp;Option C.&nbsp;Extrinsic</strong>: These terms refer to different pathways of the coagulation cascade, not directly to the maximum amplitude in TEG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;vWD</strong>: von Willebrand Disease affects platelet adhesion due to deficiency or dysfunction of von Willebrand factor, but the maximum amplitude is a function of platelet interaction with fibrin, not directly of vWD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The maximum amplitude in Thromboelastography represents platelets. TEG is a non-invasive test that quantitatively measures the ability of whole blood to form a clot.</span></p>",
      "correct_choice_id": 40070,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59611,
      "choices": [
        {
          "id": 237757,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Etomidate</span></span></span></p>"
        },
        {
          "id": 237758,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ketamine</span></span></span></p>"
        },
        {
          "id": 237759,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Propofol</span></span></span></p>"
        },
        {
          "id": 237760,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Midazolam</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 52-year-old woman with no significant past medical history is scheduled for elective laparoscopic cholecystectomy. During the preoperative discussion, the anesthesiologist explains the plan for anesthesia induction, emphasizing the importance of a rapid onset with smooth, controlled sedation. The patient expresses concern about feeling nauseous after waking up, and the anesthesiologist mentions using an agent that minimizes such risks and ensures a quick recovery. Which of the following agents is commonly used for intravenous induction of anesthesia in this scenario?</span></span></span></p>",
      "unique_key": "Q7478318",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064005,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Propofol</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Propofol is a short-acting intravenous anesthetic agent commonly used for the induction and maintenance of general anesthesia. It has a rapid onset of action, usually within 30 seconds, and provides a smooth, rapid recovery, making it highly effective for outpatient and short surgical procedures. Propofol is known for its antiemetic properties, reducing postoperative nausea and vomiting, and is often preferred for patients concerned about these side effects. However, it can cause dose-dependent hypotension and respiratory depression, requiring careful monitoring during administration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Etomidate</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Etomidate is another intravenous induction agent known for its minimal cardiovascular effects, making it suitable for patients with compromised cardiac function. However, it is not typically used as the first-line agent due to its association with adrenal suppression and increased risk of postoperative nausea and vomiting, unlike propofol.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Ketamine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Ketamine is a dissociative anesthetic that provides analgesia, sedation, and amnesia with minimal respiratory depression. It is particularly useful in trauma patients or those with risk of hypotension, but it is not commonly used for routine anesthesia induction due to its psychomimetic effects, such as vivid dreams and hallucinations during recovery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Midazolam</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Midazolam is a benzodiazepine used primarily for premedication and procedural sedation, not as a primary induction agent. It has anxiolytic, amnesic, and sedative properties but lacks the rapid onset and recovery profile of propofol, making it unsuitable for the induction of general anesthesia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Propofol is widely used for the induction and maintenance of general anesthesia due to its rapid onset, smooth induction, and quick recovery profile. It minimizes postoperative nausea and vomiting, though it requires careful monitoring for potential hypotension and respiratory depression. Other agents like etomidate, ketamine, and midazolam have specific uses but do not match propofol&#39;s overall safety and efficacy for routine induction.</span></span></span></p>",
      "correct_choice_id": 237759,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4531,
      "choices": [
        {
          "id": 18100,
          "text": "<p><span style=\"font-size:12.0pt;\">CPR with 20% intralipid</span></p>"
        },
        {
          "id": 18101,
          "text": "<p><span style=\"font-size:12.0pt;\">CPR with sodium bicarbonate</span></p>"
        },
        {
          "id": 18102,
          "text": "<p><span style=\"font-size:12.0pt;\">CPR with dobutamine</span></p>"
        },
        {
          "id": 18103,
          "text": "<p><span style=\"font-size:12.0pt;\">CPR with calcium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young male patient was given regional block with 0.25% bupivacaine for a minor surgical procedure.&nbsp;Shortly after the injection, the patient suddenly became unresponsive and the pulse was not recordable. Which of the following would be the best course of management for this patient? (NEET PG 2021)</span></p>",
      "unique_key": "Q8068662",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064006,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) CPR with 20% intralipid</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The scenario described involves a young male patient who received a regional block with 0.25% bupivacaine for a minor surgical procedure and subsequently became unresponsive with an unrecordable pulse.</span></li><li><span style=\"font-size:12.0pt;\">&nbsp;These are concerning signs of Local Anesthetic Systemic Toxicity (LAST), which can occur when local anesthetic drugs like bupivacaine enter the systemic circulation.</span></li><li><span style=\"font-size:12.0pt;\">The best course of management for this patient is as follows:</span></li><li><span style=\"font-size:12.0pt;\">This is the correct choice. Intralipid is a lipid emulsion used as the antidote for LAST.</span></li><li><span style=\"font-size:12.0pt;\">It works by sequestering the local anesthetic drug in the lipid phase and reducing its toxic effects on the cardiovascular and central nervous systems.</span></li><li><span style=\"font-size:12.0pt;\">&nbsp;CPR (Cardiopulmonary Resuscitation) should be initiated, and 20% intralipid should be administered intravenously to treat LAST.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. CPR with sodium bicarbonate</strong>: Sodium bicarbonate is not the first-line treatment for LAST. While it can be used to treat certain cardiac arrhythmias caused by local anesthetic toxicity, it does not directly counteract the toxic effects on the central nervous system and is not as effective as intralipid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CPR with dobutamine</strong>: Dobutamine is a medication used to increase cardiac output and blood pressure in some situations, but it is not the primary treatment for LAST.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CPR with calcium:</strong> Calcium does not reverse the toxic effects of local anesthetic systemic toxicity. Therefore, it is not the appropriate treatment for this situation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">When a patient experiences LAST with signs of cardiovascular collapse and central nervous system toxicity, the recommended treatment is CPR (if necessary) along with the administration of 20% intralipid intravenously, as it helps to reverse the toxic effects of the local anesthetic and improve the patient's condition.</span></li><li><span style=\"font-size:12.0pt;\">Drug of choice for treatment of LAST – 20% Intralipid IV</span></li></ul>",
      "correct_choice_id": 18100,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1030,
      "choices": [
        {
          "id": 4116,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Increase flow rate to 15 L/min</span></p>"
        },
        {
          "id": 4117,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">High-flow nasal cannula oxygen therapy</span></p>"
        },
        {
          "id": 4118,
          "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Endotracheal intubation</span></p>"
        },
        {
          "id": 4119,
          "text": "<p><span style=\"font-size:12pt;\">No specific intervention necessary</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old man who was under home isolation after testing positive for COVID-19, develops breathing difficulty and is brought to the ER. The patient is alert and responsive, but his respiratory rate is 26/min. Room air Sp02 is 86%. He is administered oxygen through a non -rebreathing mask with a flow rate of 10 L/ min. After a trial of one hour, his SpO<sub>2</sub> is 88%. What is the next step in management?</span></p>",
      "unique_key": "Q8174750",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064007,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B) High-flow nasal cannula oxygen therapy</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Mechanism of Action:</strong> HFNC can deliver warmed, humidified oxygen at high flow rates (up to 60 L/min or more), creating a positive end-expiratory pressure (PEEP) effect, reducing nasopharyngeal dead space, and improving oxygenation.</span></li><li><span style=\"font-size:12pt;\"><strong>Effectiveness:</strong> Studies have shown its effectiveness in treating acute hypoxemic respiratory failure in COVID-19 patients. Given that the patient's SpO2 didn't improve significantly with an NRB, transitioning to HFNC might be a logical step before considering more invasive measures like intubation.</span></li></ul><p>&nbsp;</p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Increase flow rate to 15 L/min: </strong>The non-rebreather mask (NRB) is designed to deliver high concentrations of oxygen (up to 90%). Increasing the flow rate may slightly improve the fraction of delivered oxygen, but it may not result in significant improvement in oxygenation, especially if the cause of hypoxia isn't just a low FiO2. Therefore, merely increasing the flow rate may not be sufficient to address the patient's respiratory distress.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Endotracheal intubation: </strong>Endotracheal intubation and mechanical ventilation are invasive interventions, reserved for patients who are in respiratory failure and cannot maintain adequate oxygenation and/or ventilation with less invasive means. While this patient is hypoxic, jumping straight to intubation without trialing intermediate steps like HFNC might be premature, especially since the patient is alert and responsive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. No specific intervention necessary: </strong>Given the patient's low SpO2 and increased respiratory rate, no intervention is not an appropriate choice. The patient is in respiratory distress and requires further measures to improve his oxygenation.</span></p><p>&nbsp;</p><p><span style=\"color:#434343;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">In a patient with COVID-19 and hypoxemia unresponsive to a non-rebreather mask, transitioning to high-flow nasal cannula oxygen therapy (HFNC) is a logical next step. HFNC can provide better oxygenation and is a less invasive option before considering endotracheal intubation.</span></li></ul>",
      "correct_choice_id": 4117,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1004,
      "choices": [
        {
          "id": 4012,
          "text": "<p><span style=\"font-size:12pt;\">Automated External Desynchronizer</span></p>"
        },
        {
          "id": 4013,
          "text": "<p><span style=\"font-size:12pt;\">Automated External Defibrillator</span></p>"
        },
        {
          "id": 4014,
          "text": "<p><span style=\"font-size:12pt;\">Automated Electronic Defibrillator</span></p>"
        },
        {
          "id": 4015,
          "text": "<p><span style=\"font-size:12pt;\">Automated External decompressor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Identify the device shown in the image below?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/02/screenshot-2024-07-02-153116.jpg\" alt=\"\" width=\"300\" height=\"398\"></span></p>",
      "unique_key": "Q1883147",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064008,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Automated External Defibrillator</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Automated External Defibrillator (AED):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Definition:</strong> An automated external defibrillator (AED) is a portable electronic device that automatically diagnoses the life-threatening cardiac arrhythmias of ventricular fibrillation (VF) and pulseless ventricular tachycardia, and is able to treat them through defibrillation, the application of electricity which stops the arrhythmia, allowing the heart to re-establish an effective rhythm.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Rapid Defibrillation:</strong> Rapid defibrillation is paramount in improving survival rates from sudden cardiac arrest due to ventricular fibrillation or pulseless ventricular tachycardia.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>User-Friendly and Accessible:</strong> AEDs are made for laypersons and first responders, not just for medical professionals. They come with voice prompts and sometimes visual displays to guide the user through each step of the defibrillation process. This design makes it possible for people without extensive medical training to assist in a cardiac emergency.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Self-Analyzing:</strong> An AED automatically evaluates the heart rhythm of a person in cardiac arrest. If the device detects a shockable rhythm, it will instruct the user to deliver a shock; if not, it will guide the user to continue with CPR or other appropriate interventions. This ensures that shocks are only given when necessary.</span></li></ul><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Public Availability:</strong> Many public places such as airports, gyms, schools, and shopping centers have publicly accessible AEDs. Increasing the availability and visibility of AEDs in public spaces can reduce the time to defibrillation and increase survival rates from out-of-hospital cardiac arrest.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Automated External Desynchronizer: </strong>This term is incorrect and not associated with any known medical device.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Automated Electronic Defibrillator: </strong>This term is incorrect and not associated with any known medical device.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Automated External Decompressor: </strong>This term is incorrect and not associated with any known medical device.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">An Automated External Defibrillator (AED) is a crucial device for rapidly diagnosing and treating life-threatening cardiac arrhythmias through defibrillation, especially designed for use by laypersons and first responders to increase survival rates in cases of sudden cardiac arrest.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Miller’s Anesthesia, 9<sup>th</sup> Ed. Pg</strong> <strong>2537</strong></span></p>",
      "correct_choice_id": 4013,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ImageBased",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 573,
      "choices": [
        {
          "id": 2288,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">5 L/min</span></p>"
        },
        {
          "id": 2289,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">15 L/min</span></p>"
        },
        {
          "id": 2290,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">10 L/min</span></p>"
        },
        {
          "id": 2291,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">20 L/min</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The maximum oxygen flow rate which can be kept with a conventional Hudson oxygen mask is?</span></p>",
      "unique_key": "Q4102126",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064009,
      "difficulty_level": "intermediate",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. 10 L/min</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The maximum oxygen flow rate which can be kept with a conventional oxygen mask (Simple Face Mask, also known as Hudson mask) is 10 L/min. This is a standard setting for delivering oxygen to patients who require moderate levels of oxygen supplementation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;A. 5 L/min:</strong> While 5 L/min can be used, it is not the maximum flow rate for a Hudson mask.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B. 15 L/min</strong>: This flow rate is generally used with a non-rebreather mask rather than a conventional Hudson mask.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;D. 20 L/min:</strong> This flow rate exceeds the capacity of most conventional oxygen delivery systems like the Hudson mask.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The maximum flow rate for a conventional Hudson oxygen mask is 10 L/min.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/06/screenshot-2024-07-06-134044.jpg\" alt=\"\" width=\"700\" height=\"196\"></span></p>",
      "correct_choice_id": 2290,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11728,
      "choices": [
        {
          "id": 46878,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune adrenalitis</span></p>"
        },
        {
          "id": 46879,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypernephroma</span></p>"
        },
        {
          "id": 46880,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenocortical carcinoma</span></p>"
        },
        {
          "id": 46881,
          "text": "<p><span style=\"font-size:12.0pt;\">Medullary carcinoma thyroid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Addison's disease is commonly associated with:&nbsp;(AIIMS NOV 2019)</span></p>",
      "unique_key": "Q1342696",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064230,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Autoimmune adrenalitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Addison's disease, primarily characterized by adrenal insufficiency, is most commonly associated with autoimmune adrenalitis. In this condition, the body's immune system attacks the adrenal cortex, leading to a decrease in the production of steroid hormones such as cortisol and aldosterone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hypernephroma:&nbsp;</strong>Also known as renal cell carcinoma, hypernephroma is a type of kidney cancer and has no direct link to the adrenal function or Addison's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Adrenocortical carcinoma:&nbsp;</strong>This is a cancer of the adrenal cortex but typically leads to excessive hormone production, associated more with Cushing's syndrome rather than Addison's disease, where there is hormone deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Medullary carcinoma of the thyroid:&nbsp;</strong>This type of cancer is associated with the thyroid gland and is related to multiple endocrine neoplasia type 2 (MEN2) syndrome but not directly linked to Addison's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:11.0pt;\">Addison's disease is most commonly caused by autoimmune adrenalitis, where the immune system mistakenly attacks the adrenal glands, leading to insufficient production of vital hormones.</span></p>",
      "correct_choice_id": 46878,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4092,
      "choices": [
        {
          "id": 16347,
          "text": "<p><span style=\"font-size:12.0pt;\">C &amp; D only</span></p>"
        },
        {
          "id": 16348,
          "text": "<p><span style=\"font-size:12.0pt;\">A, B, C &amp; D</span></p>"
        },
        {
          "id": 16349,
          "text": "<p><span style=\"font-size:12.0pt;\">A, B &amp; C</span></p>"
        },
        {
          "id": 16350,
          "text": "<p><span style=\"font-size:12.0pt;\">A &amp; B only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following are true about chancroid: (INICET NOV 2020)</span></p><p>&nbsp;</p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">School of fish appearance</span></li><li><span style=\"font-size:12.0pt;\">Bleeds on touch</span></li><li><span style=\"font-size:12.0pt;\">Painful</span></li><li><span style=\"font-size:12.0pt;\">Groove sign</span></li></ol>",
      "unique_key": "Q2818472",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064231,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) A, B, &amp; C</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chancroid is caused by the bacterium <strong>Hemophilus ducreyi</strong> and results in <strong>painful, superficial ulcers, often with regional lymphadenopathy.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">H. ducreyi is a small, fastidious gram-negative rod that requires an enriched growth medium cultivated in a high humidity, CO2-enriched environment. On Gram stain, long strands of organisms are seen in a pattern often referred to as a \"<strong>school of fish\" or \"railroad track\" in appearance</strong>.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Typically, an erythematous papule develops at the site of inoculation, which quickly becomes a pustule and subsequently develops into an <strong>extremely painful ulcer</strong> with soft irregular margins, often referred to as a \"<strong>soft chancre</strong>.\" Multiple ulcers may be noted either as a result of multiple areas of microtrauma or as a result of direct contact between two adjacent areas resulting in <strong>\"kissing ulcers.\"</strong> The ulcer typically has a friable base with yellow-gray exudate, which <strong>easily bleeds</strong> when abraded and varies in size, <u>typically from 1 to 2 cm. Left untreated, the lesion spontaneously resolves within 1 to 3 months.</u></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>D. Groove sign:</strong> This is typically associated with lymphogranuloma venereum (LGV) and not chancroid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chancroid, caused by Haemophilus ducreyi, is characterized by painful ulcers with a friable base that easily bleeds and has a \"school of fish\" appearance on Gram stain. The \"groove sign\" is not associated with chancroid but rather with lymphogranuloma venereum (LGV).</span></p>",
      "correct_choice_id": 16349,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4508,
      "choices": [
        {
          "id": 18008,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Physostigmine</span></p>"
        },
        {
          "id": 18009,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Neostigmine</span></p>"
        },
        {
          "id": 18010,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Carbachol</span></p>"
        },
        {
          "id": 18011,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Succinylcholine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient is given a nicotinic receptor antagonist as a muscle relaxant. Which drug is given postoperatively to recover from muscle weakness? (NEET PG 2020)</span></p>",
      "unique_key": "Q4269626",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064232,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Neostigmine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For reversal of neuromuscular blockade from non-depolarizing muscle relaxants, the reversal agent of choice is Neostigmine.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Neostigmine is a cholinesterase inhibitor that boosts the concentration of acetylcholine in the neuromuscular junction, thus enhancing muscle contraction.</span></li><li><span style=\"font-size:12.0pt;\">Neostigmine is the drug of choice for reversing the effects of non-depolarizing muscle relaxants postoperatively. By preventing the breakdown of acetylcholine, it counteracts the muscle-relaxing effects of these drugs.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Physostigmine:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Physostigmine is a reversible cholinesterase inhibitor. It increases the concentration of acetylcholine at nerve endings.</span></li><li><span style=\"font-size:12.0pt;\">Physostigmine is primarily used to treat anticholinergic (atropine-like) drug overdoses. It can cross the blood-brain barrier and is used for central anticholinergic syndromes. It is not typically used for reversing neuromuscular blockade from muscle relaxants.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Carbachol:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Carbachol is a cholinergic drug that acts as an agonist at both muscarinic and nicotinic receptors.</span></li><li><span style=\"font-size:12.0pt;\">Carbachol is primarily used in ophthalmology to induce miosis or to reduce intraocular pressure. It is not used for reversing neuromuscular blockade.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Succinylcholine:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Succinylcholine is a depolarizing neuromuscular blocker. It binds to nicotinic receptors and causes prolonged depolarization, which initially causes muscle fasciculation followed by paralysis.</span></li><li><span style=\"font-size:12.0pt;\">Succinylcholine itself causes muscle paralysis and is used to facilitate intubation during anesthesia induction. It would not be used to reverse muscle relaxation; in fact, it would exacerbate it.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neostigmine is the preferred agent for reversing the effects of non-depolarizing muscle relaxants postoperatively.</span></p>",
      "correct_choice_id": 18009,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59612,
      "choices": [
        {
          "id": 237761,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mepivacaine</span></span></span></p>"
        },
        {
          "id": 237762,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prilocaine</span></span></span></p>"
        },
        {
          "id": 237763,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cocaine</span></span></span></p>"
        },
        {
          "id": 237764,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Procaine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 35-year-old man presents to the emergency department with a laceration on his arm sustained during a fall. He reports significant pain, and a local anesthetic is planned for wound closure. During the procedure, the patient becomes restless, agitated, and his blood pressure rises to 180/100 mmHg. Upon further questioning, the patient admits to using a substance recreationally that he believes is responsible for his symptoms. Which of the following local anesthetics is most likely causing his hypertension?</span></span></span></p>",
      "unique_key": "Q1740919",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064387,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Cocaine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cocaine is an ester local anesthetic with strong vasoconstrictive properties, leading to hypertension as one of its cardiovascular effects. Cocaine acts as a powerful stimulant of the central nervous system by blocking the reuptake of norepinephrine, dopamine, and serotonin, thereby increasing sympathetic tone. This results in vasoconstriction, elevated heart rate, and raised blood pressure. Due to these potent vasoconstrictive effects, cocaine can induce hypertension, even at small doses, making it unique among local anesthetics.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Mepivacaine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Mepivacaine is an amide local anesthetic used for regional anesthesia with minimal cardiovascular effects. It does not possess significant vasoconstrictive properties and is unlikely to cause hypertension, making it a safer choice compared to cocaine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Prilocaine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Prilocaine is an amide local anesthetic commonly used for regional anesthesia and dental procedures. While it is associated with methemoglobinemia as a potential side effect, it does not have significant vasoconstrictive properties and does not cause hypertension. Prilocaine primarily acts by blocking sodium channels in nerve fibers, reducing nerve signal transmission.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Procaine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Procaine, an ester local anesthetic, has a short duration of action and does not have the same vasoconstrictive or hypertensive effects as cocaine. It is primarily used in minor procedures and is considered relatively safe regarding cardiovascular side effects.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cocaine is a local anesthetic that causes hypertension due to its potent vasoconstrictive effects and central nervous system stimulation. It works by blocking the reuptake of norepinephrine, dopamine, and serotonin, increasing sympathetic activity and blood pressure, distinguishing it from other local anesthetics that lack these effects.</span></span></span></p>",
      "correct_choice_id": 237763,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20355,
      "choices": [
        {
          "id": 81381,
          "text": "<p><span style=\"font-size:18px;\">Collect water from already leaking taps</span></p>"
        },
        {
          "id": 81382,
          "text": "<p><span style=\"font-size:18px;\">Before collecting, let water flow for at least 1 minute</span></p>"
        },
        {
          "id": 81383,
          "text": "<p><span style=\"font-size:18px;\">Water sample container is kept close to the tap avoid spillage</span></p>"
        },
        {
          "id": 81384,
          "text": "<p><span style=\"font-size:18px;\">Collect from a gentle stream of water to avoid splashing</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:18px;\"><strong>How is water collected for bacteriological examination during a disease outbreak? </strong><i><strong>[NEET PG 2023]</strong></i></span></p>",
      "unique_key": "Q1903602",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064488,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (d) Collect from a gentle stream of water to avoid splashing</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">When collecting water for bacteriological examination, especially during a disease outbreak, it is crucial to follow proper procedures to avoid contamination and ensure the sample's accuracy. The best practice is to collect water from a gentle stream to avoid splashing, which can introduce contaminants from the environment into the sample.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. Collect water from already leaking tape:&nbsp;</strong>Not recommended as it could contaminate the sample and may lead to false results.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Before collecting, let water flow for at least 1 minute</strong>: Before collecting, let water flow for at least 2 minutes</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Water sample container is kept close to the tap to avoid spillage:&nbsp;</strong>It is a good practice but this practice alone does not ensure the proper collection of the sample.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">When collecting water for bacteriological examination during a disease outbreak, it is crucial to collect from a gentle stream of water to avoid splashing and potential contamination. This practice ensures the accuracy and reliability of the water sample.</span></p>",
      "correct_choice_id": 81384,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44852,
      "choices": [
        {
          "id": 179055,
          "text": "<p><span style=\"font-size:12pt;\">1, 2 and 4</span></p>"
        },
        {
          "id": 179056,
          "text": "<p><span style=\"font-size:12pt;\">1, 3 and 4</span></p>"
        },
        {
          "id": 179057,
          "text": "<p><span style=\"font-size:12pt;\">1, 2 and 3</span></p>"
        },
        {
          "id": 179058,
          "text": "<p><span style=\"font-size:12pt;\">2, 3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following drug is/are used for cyanide poisoning?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Amyl nitrite</span></li><li><span style=\"font-size:12pt;\">Sodium nitrite</span></li><li><span style=\"font-size:12pt;\">Sodium thiosulfate</span></li><li><span style=\"font-size:12pt;\">Glyceryl trinitrate</span></li></ol>",
      "unique_key": "Q8757926",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064489,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 1, 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For cyanide poisoning, the following treatments are commonly used:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1.</strong>&nbsp;<strong>Amyl nitrite</strong>: This is an inhalant that induces methemoglobinemia, which binds cyanide ions and forms cyanmethemoglobin, helping to detoxify cyanide.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12pt;\">2&nbsp;<strong>Sodium nitrite</strong>: This intravenous agent also induces methemoglobinemia, which helps to bind and neutralize cyanide.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3.</strong>&nbsp;<strong>Sodium thiosulfate</strong>: This acts as a sulfur donor, converting cyanide to the less toxic thiocyanate, which is excreted by the kidneys.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4.</strong>&nbsp;<strong>Glyceryl trinitrate</strong> (commonly known as nitroglycerin) is not typically used for cyanide poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Based on the options provided, the correct combination of drugs used for cyanide poisoning is:&nbsp;<strong>1, 2, and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Therefore, the correct answer is:&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C. 1, 2, and 3</strong></span></p>",
      "correct_choice_id": 179057,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3513,
      "choices": [
        {
          "id": 14031,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Toluidine blue &#39;O&#39; and malachite green</span></span></span></p>"
        },
        {
          "id": 14032,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Carbol fuschin and methylene blue</span></span></span></p>"
        },
        {
          "id": 14033,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Carbol fuschin and malachite green</span></span></span></p>"
        },
        {
          "id": 14034,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Toluidine and methylene blue</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient has complained of fever with chills. A throat examination reveals swollen glands and a thick, whitish membrane over his tonsils. Albert staining is to be done. What are the constituents of Albert&#39;s stain?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2020)</span></span></p>",
      "unique_key": "Q3820366",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064490,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Toluidine blue &lsquo;O&rsquo; and malachite green </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Albert stain is a type of differential stain used for staining high-molecular-weight polymers of polyphosphate known as <strong>metachromatic granules or volutin granules found in C<u>orynebacterium</u>&nbsp;</strong>diphtheriae. <strong>Metachromatic granules are also found in <u>Yersinia pestis, and Mycobacterium</u></strong> species.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Albert stain is composed of two reagents:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Albert&rsquo;s A solution consist of</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Toluidine blue - 0.15 gm</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Malachite green - 0.20 gm</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glacial acetic acid - 1 ml</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alcohol (95% ethanol) - 2ml</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dissolve the dyes in alcohol and add to the distilled water and acetic acid. Allow the stain to stand for one day and then filter. Add Distilled water to make the final volume 100ml.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Albert&rsquo;s B solution consist of</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Iodine - 2gm</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Potassium iodide (KI) - 3 gm</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dissolve KI in water and then add iodine. Dissolve iodine in potassium iodide solution</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Albert stain is basically made up of two stains that are toluidine blue&rsquo; O&rsquo; and malachite green both of which are basic dyes with high affinity for acidic tissue components like cytoplasm. The pH of Albert stain is adjusted to 2.8 by using acetic acid which becomes basic for volutin granules as the pH of volutin granule is highly acidic. Therefore, on applying Albert&rsquo;s stain to the smear, toluidine blue&rsquo; O&rsquo; stains volutin granules i.e the most acidic part of cell and malachite green stains the cytoplasm blue-green. On adding Albert&rsquo;s iodine due to effect of iodine, the metachromatic property is not observed and granules appear blue in color.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-265.jpg\" style=\"height:611px; width:700px\" /></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Carbol fuschin and methylene blue</strong>: This combination is typically used in acid-fast staining (Ziehl-Neelsen stain) for mycobacteria.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Carbol fuschin and malachite green</strong>: This combination is not typically used for staining metachromatic granules.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Toluidine and methylene blue</strong>: This combination is not specific for metachromatic granules and is not used in Albert staining.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Albert stain, which contains Toluidine blue &#39;O&#39; and Malachite green, is specifically used for staining metachromatic granules in <em>Corynebacterium diphtheriae</em>. These granules are an important diagnostic feature for diphtheria.</span></span></span></p>",
      "correct_choice_id": 14031,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8792,
      "choices": [
        {
          "id": 35135,
          "text": "<p><span style=\"font-size:12.0pt;\">Fine touch lost on the opposite side</span></p>"
        },
        {
          "id": 35136,
          "text": "<p><span style=\"font-size:12.0pt;\">Pain and temperature lost on the same side</span></p>"
        },
        {
          "id": 35137,
          "text": "<p><span style=\"font-size:12.0pt;\">Pain and temperature loss on the opposite side</span></p>"
        },
        {
          "id": 35138,
          "text": "<p><span style=\"font-size:12.0pt;\">Only pain lost on the same side</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Brown Sequard syndrome is characterized by?&nbsp;</span>(NEET PG 2019)</p>",
      "unique_key": "Q7589843",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064491,
      "difficulty_level": "beginner",
      "subjects_id": [
        2
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Pain and temperature loss on the opposite side</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Brown-Sequard syndrome results from a hemisection (partial transection) of the spinal cord, leading to a distinct pattern of neurological symptoms:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Ipsilateral (same side as the lesion) Deficits</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Motor Function</strong>: There is paralysis below the level of the lesion due to damage to the corticospinal tract, which controls voluntary muscle movements. The paralysis is of the upper motor neuron type, characterized by increased muscle tone, spasticity, and hyperreflexia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Proprioception and Discriminative Touch</strong>: Loss of fine touch, vibration sense, proprioception, and discriminatory tactile abilities due to damage to the dorsal columns (fasciculus gracilis and fasciculus cuneatus) which carry these sensory modalities from the body to the brain.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Contralateral (opposite side as the lesion) Deficits</strong>:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Pain and Temperature Sensation</strong>: Loss occurs below the level of the lesion because the spinothalamic tract, which carries pain and temperature sensations, crosses over to the opposite side at the level of the spinal cord soon after entering. Thus, a hemisection will affect the fibers carrying information from the opposite side.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/10/680.jpg\" alt=\"\" width=\"700\" height=\"477\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Fine touch lost on the opposite side</strong>: Incorrect because fine touch is lost on the same side as the lesion, not the opposite.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pain and temperature lost on the same side</strong>: Incorrect as pain and temperature sensations are lost on the opposite side due to the crossing of the spinothalamic tract.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Only pain lost on the same side</strong>: Incorrect because pain sensation is lost on the opposite side and is associated with temperature loss as well.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hemi section of the spinal cord involves the ascending sensory (dorsal column pathway, ventrolateral spinothalamic tract) and descending motor (corticospinal tract) pathways, which is called the Brown- Sequard syndrome.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/27/screenshot-2024-05-27-102208.png\" alt=\"\" width=\"1000\" height=\"1036\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Functions of tracts involved -</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Fasciculus gracilis or fasciculus cuneatus → ipsilateral discriminative touch, vibration, and proprioception</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Spinothalamic tract → contralateral pain and temperature sensation</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Corticospinal tract → primary motor activity same side of the body.</span></p>",
      "correct_choice_id": 35137,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4193,
      "choices": [
        {
          "id": 16751,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cytotoxic T cells</span></span></span></p>"
        },
        {
          "id": 16752,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B cells</span></span></span></p>"
        },
        {
          "id": 16753,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">NK cells</span></span></span></p>"
        },
        {
          "id": 16754,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Helper cells</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Antigen binding to MHC class I activates which of the following cells? (INICET MAY 2022)</span></span></span></p>",
      "unique_key": "Q3006868",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064492,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Cytotoxic T cells</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cytotoxic T cells</span></strong><span style=\"font-size:12.0pt\">: MHC class I molecules present endogenous antigens, typically derived from intracellular proteins, to cytotoxic T cells (also known as CD8+ T cells). When a cytotoxic T cell recognizes an antigen presented by MHC class I on the surface of a cell, it is activated to destroy the infected or malignant cell.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>B cells</strong>: B cells are activated by antigens presented by MHC class II molecules on antigen-presenting cells (APCs) and by direct interaction with helper T cells (CD4+ T cells), not by MHC class I.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>NK cells</strong>: Natural Killer (NK) cells do not rely on MHC class I molecules for activation. In fact, they often target cells with low or absent MHC class I expression, which is a common strategy of infected or transformed cells to evade cytotoxic T cells.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Helper cells</strong>: Helper T cells (CD4+ T cells) are activated by antigens presented by MHC class II molecules on APCs, not by MHC class I.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/28/screenshot-2024-06-28-135737.png\" style=\"height:468px; width:1000px\" /></p>",
      "correct_choice_id": 16751,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5871,
      "choices": [
        {
          "id": 23454,
          "text": "<p><span style=\"font-size:12pt;\">For tubal ligation</span></p>"
        },
        {
          "id": 23455,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿For ligation of uterine artery during hysterectomy</span></p>"
        },
        {
          "id": 23456,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Ovarian cystectomy</span></p>"
        },
        {
          "id": 23457,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Ectopic pregnancy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Identify the use of the instrument given below?</span><span style=\"font-size:12.0pt;\">&nbsp;</span>(NEET PG 2020)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/picture6.jpg\" alt=\"\" width=\"400\" height=\"147\"></span></p>",
      "unique_key": "Q8499431",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064493,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) For tubal ligation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The instrument shown is a laparoscopic ring applicator, also known as a laparocator. It is specifically designed for tubal ligation procedures. The instrument is used to apply Falope rings (silastic bands) on the fallopian tubes, which effectively block the tubes and prevent pregnancy. The Falope rings are preloaded on the tip of the instrument and are released after grasping the fallopian tube, thereby occluding the lumen.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. For ligation of uterine artery during hysterectomy:</strong> This is incorrect. The instrument shown is not used for ligating the uterine artery. Instead, instruments like clamps or ligature carriers are typically used for this purpose during a hysterectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Ovarian cystectomy:</strong> This is incorrect. The instrument is not used for ovarian cystectomy, which involves the removal of cysts from the ovary. Instruments like scissors, graspers, and cautery devices are commonly used in ovarian cystectomy procedures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Ectopic pregnancy:</strong> This is incorrect. While laparoscopic instruments are used in the surgical management of ectopic pregnancy, the specific instrument shown (laparoscopic ring applicator) is not used for this purpose. Instruments used for ectopic pregnancy surgery include laparoscopic graspers, scissors, and suction devices.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The laparoscopic ring applicator (laparocator) is used for applying Falope rings during tubal ligation procedures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 497, DC Dutta’s Textbook of Gynecology, 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23454,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "InstrumentsBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7473,
      "choices": [
        {
          "id": 29860,
          "text": "<p><span style=\"font-size:12pt;\">Pityriasis rotunda</span></p>"
        },
        {
          "id": 29861,
          "text": "<p><span style=\"font-size:12pt;\">Melasma</span></p>"
        },
        {
          "id": 29862,
          "text": "<p><span style=\"font-size:12.0pt;\">Dermatomyositis</span></p>"
        },
        {
          "id": 29863,
          "text": "<p><span style=\"font-size:12pt;\">Acanthosis nigricans</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the condition given in the image:&nbsp;</span>&nbsp;(NEET PG 2019)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-1331.jpg\" alt=\"\" width=\"300\" height=\"380\"></p>",
      "unique_key": "Q5513658",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064494,
      "difficulty_level": "beginner",
      "subjects_id": [
        18
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;D. Acanthosis nigricans</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Acanthosis nigricans</strong> is the illness depicted in the image.</span></li><li><span style=\"font-size:12.0pt;\">It is characterized by <strong>thickened, gray-brown velvety plaques</strong> seen in <strong>flexural</strong> areas such as the back of the neck, axillae, inframammary creases, waist, and groin.</span></li><li><span style=\"font-size:12.0pt;\">The release of <strong>epidermal growth factors</strong> in the affected area is the causal mechanism.</span></li><li><span style=\"font-size:12.0pt;\">Acanthosis Nigricans may be benign or linked to a malignancy.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/screenshot-2023-09-27-194248.jpg\" alt=\"\" width=\"1000\" height=\"173\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Acanthosis nigricans can also be seen in the following:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Multiple <strong>seborrhoeic keratoses</strong></span></li><li><span style=\"font-size:12.0pt;\">Drugs like <strong>nicotinic acid</strong> (Use for hyperlipidaemia treatment)</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Other conditions associated with metabolic syndrome include <strong>polycystic ovarian</strong> syndrome, sleep apnea &amp; <strong>non-alcoholic fatty liver disease</strong>.</span></li><li><span style=\"font-size:12.0pt;\">The condition is managed by <strong>dietary &amp; lifestyle</strong> modifications.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Pityriasis rotunda</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Description:</strong> This is a rare skin condition characterized by <strong>large, round patches of dry, scaly skin as shown in the image below</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/27/screenshot-2023-09-27-194249.jpg\" alt=\"\" width=\"400\" height=\"261\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Melasma</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Description:</strong> Melasma is characterized by <strong>brown to gray-brown patches</strong>, mainly on the <strong>face</strong> (cheeks, bridge of the nose, forehead, chin, and above the upper lip). It's often called the <strong>\"mask of pregnancy.\"</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> <strong>Dermatomyositis</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Description:</strong> An <strong>inflammatory muscle disease</strong>, dermatomyositis presents with skin rash and <strong>muscle weakness</strong>. The rash is often <strong>reddish or purple</strong>, seen on the <strong>eyelids, knuckles, elbows, knees</strong>, and sometimes the chest and back.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">E<strong>ducational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Acanthosis nigricans</strong> is marked by a <strong>velvety darkening</strong> of the skin in body <strong>folds.</strong></span></li><li><span style=\"font-size:12pt;\">There's a notable link between <strong>obesity, acanthosis nigricans</strong>, and <strong>metabolic syndrome</strong>, with the latter condition often being a visible indicator of <strong>insulin resistance</strong>.</span></li><li><span style=\"font-size:12pt;\">Recognizing <strong>acanthosis nigricans</strong> is vital as it can be a marker of underlying <strong>systemic issues</strong> that may require comprehensive <strong>medical evaluation.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>References: Rook's Textbook of Dermatology 9th edition Chapter 147, Page nos 147.14-147.15</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Williams Gynecology 3rd edition Page no 391</strong></span></p>",
      "correct_choice_id": 29863,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12832,
      "choices": [
        {
          "id": 51290,
          "text": "<p><span style=\"font-size:12pt;\">In Africanoids the cusps of molars are wide and deep with shovel shaped cusps in incisors</span></p>"
        },
        {
          "id": 51291,
          "text": "<p><span style=\"font-size:12pt;\">Caucasians have carabelli cusps</span></p>"
        },
        {
          "id": 51292,
          "text": "<p><span style=\"font-size:12pt;\">Upper third molar is most commonly absent in Mongolians</span></p>"
        },
        {
          "id": 51293,
          "text": "<p><span style=\"font-size:12pt;\">Prominent lingual ridge and labial ridge in mongols</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Identify the false statement regarding teeth and ethnicity?</span></p>",
      "unique_key": "Q3522578",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064495,
      "difficulty_level": "difficult",
      "subjects_id": [
        10
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. In Africanoids the cusps of molars are wide and deep with shovel shaped cusps in incisors</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The</span><span style=\"font-size:9pt;\"> </span><span style=\"font-size:12.0pt;\">cusps of molars are wide and deep and cusps of incisors are shovel-shaped is typically seen in Mongoloid races not in Africanoids hence the statement is incorrect. In Africanoids there is presence of large teeth and often have more cusps on their molars, even up to eight, with two lingual cusps on the mandibular first premolars as an additional common finding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B), Option C), Option D):&nbsp;</strong>these statements are correct as explained in the core concept above. The question is asking for the wrong statement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key differences between race</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/11/screenshot-2024-06-11-142652.png\" alt=\"\" width=\"1000\" height=\"719\"></strong></span></p>",
      "correct_choice_id": 51290,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13040,
      "choices": [
        {
          "id": 52122,
          "text": "<p><span style=\"font-size:12.0pt;\">Hereditary spastic quadriplegia</span></p>"
        },
        {
          "id": 52123,
          "text": "<p><span style=\"font-size:12.0pt;\">Subacute combined degeneration</span></p>"
        },
        {
          "id": 52124,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuromyelitis optica</span></p>"
        },
        {
          "id": 52125,
          "text": "<p><span style=\"font-size:12.0pt;\">Multiple sclerosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old female patient presents with 6/60 visual acuity in one eye and 6/18 in the other eye. She has recurrent episodes of diminution of vision which recovers on treatment with steroids. She also has a history of transverse myelitis. What is the most probable diagnosis?</span></p>",
      "unique_key": "Q7322882",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064516,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Neuromyelitis optica</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The most probable diagnosis is neuromyelitis optica (NMO).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">NMO is a demyelinating autoimmune disease that primarily affects the optic nerves and spinal cord. Patients with NMO can present with recurrent episodes of optic neuritis, which can result in decreased visual acuity, as well as myelitis, which can cause weakness, sensory loss, and bladder dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's history of recurrent episodes of diminution of vision that recovers on treatment with steroids is consistent with optic neuritis, which is a common presenting feature of NMO. The history of transverse myelitis also supports a diagnosis of NMO, as myelitis is a common feature of the disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Management of acute attacks:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">High-dose glucocorticoids</span></li><li><span style=\"font-size:12.0pt;\">Plasma exchange.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Drugs used for prophylaxis against relapses:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Mycophenolate mofetil</span></li><li><span style=\"font-size:12.0pt;\">Rituximab</span></li><li><span style=\"font-size:12.0pt;\">Glucocorticoids</span></li><li><span style=\"font-size:12.0pt;\">Azathioprine.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hereditary spastic quadriplegia:</strong> This is a genetic disorder affecting motor functions and does not involve optic neuritis or transverse myelitis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Subacute combined degeneration:</strong> Typically associated with vitamin B12 deficiency affecting the spinal cord, but not specifically linked with optic neuritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Multiple sclerosis (MS):</strong> While MS can present with symptoms similar to NMO, including optic neuritis and spinal cord involvement, the pattern of attacks and the severity of symptoms in the context of transverse myelitis point more specifically to NMO, especially considering the distinct pathophysiology and antibody profiles (e.g., anti-aquaporin-4 antibodies).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neuromyelitis optica should be considered in patients presenting with recurrent optic neuritis and transverse myelitis, especially when there is a good response to steroid treatment. Distinguishing NMO from multiple sclerosis is crucial, as treatment and prognosis differ significantly between these conditions.</span></p>",
      "correct_choice_id": 52124,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11075,
      "choices": [
        {
          "id": 44266,
          "text": "<p><span style=\"font-size:18px;\">COV of DBP is more than Vitamin D</span></p>"
        },
        {
          "id": 44267,
          "text": "<p><span style=\"font-size:18px;\">COV of Vitamin D is more than DBP</span></p>"
        },
        {
          "id": 44268,
          "text": "<p><span style=\"font-size:18px;\">Both DBP and Vitamin D have equal variability</span></p>"
        },
        {
          "id": 44269,
          "text": "<p><span style=\"font-size:18px;\">It cannot be ascertained from information provided</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>During your clinical rotations, you are reviewing data from an experiment that examined the correlation between Vitamin D levels and diastolic blood pressure (DBP). The experiment aimed to ascertain the variability within two distinct sample sets. Based on the findings, the average DBP was noted to be 110, with an associated standard deviation of 11. Similarly, the mean Vitamin D level was observed to be 18, with a standard deviation of 3. With reference to the coefficient of variation (COV), which statement accurately represents the collected data? </strong><i><strong>[AIIMS MAY 2019]</strong></i></span></p>",
      "unique_key": "Q5980809",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064517,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (b) COV of Vitamin D is more than DBP</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Coefficient of Variation (COV)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Is a measure used to compare relative variability</span></li><li><span style=\"font-size:18px;\">Is a unit-free measure to compare dispersion of one variable with another</span></li><li><span style=\"font-size:18px;\">Is SD expressed as percentage of mean</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/23/screenshot-2023-10-23-125116.jpg\" alt=\"\" width=\"300\" height=\"51\"></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Calculation -</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">COV of DBP = 11/110 = 0.1</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">COV of Vitamin D = 3/18 = 0.166</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Hence, COV of Vitamin D is more than DBP</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The coefficient of variation provides a useful comparison of variability across different datasets.</span></li><li><span style=\"font-size:18px;\">In this case, the higher COV for Vitamin D indicates a greater relative variation compared to DBP, highlighting important considerations for researchers analyzing the impacts or associations involving these variables.</span></li></ul>",
      "correct_choice_id": 44267,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11290,
      "choices": [
        {
          "id": 45126,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liddle&#39;s syndrome</span></span></p>"
        },
        {
          "id": 45127,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nephrogenic DI</span></span></p>"
        },
        {
          "id": 45128,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cystic fibrosis</span></span></p>"
        },
        {
          "id": 45129,
          "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bartter syndrome</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A mutation in the gene for aquaporin channel leads to which of the following conditions? (NEET PG 2020)</span></span></p>",
      "unique_key": "Q6275126",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064518,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Nephrogenic DI</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nephrogenic diabetes insipidus (DI) is caused by a mutation in the genes that encode for aquaporin channels, specifically Aquaporin-2. These channels are involved in water reabsorption in the kidney&#39;s collecting ducts. A defect in these channels impairs the kidney&#39;s ability to concentrate urine in response to antidiuretic hormone (ADH), leading to the excretion of large amounts of dilute urine, despite the presence of adequate or even elevated levels of ADH.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liddle syndrome: </span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Is characterized by <strong>gain of function mutation of ENaC channels</strong> causing HTN, Hypokalemia with metabolic alkalosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cystic fibrosis:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Occurs due to <strong>mutation in CFTR membrane proteins</strong>.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Occurs due to <strong>mutation in Ascending Loop of Henle</strong> (Na-K-CL /Bertin/NA-Cl transporters).</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: &nbsp;</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A mutation in the aquaporin channels, particularly Aquaporin-2, leads to nephrogenic diabetes insipidus. This condition is characterized by an inability of the kidneys to concentrate urine in response to ADH, resulting in the production of large volumes of dilute urine. Understanding the genetic basis of nephrogenic DI is crucial for accurate diagnosis and management, which typically involves addressing the symptoms and managing water intake rather than hormone therapy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison/Diabetes Insipidus/Chapter 381</span></span></strong></p>",
      "correct_choice_id": 45127,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10107,
      "choices": [
        {
          "id": 40394,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Image 2</span></span></span></p>"
        },
        {
          "id": 40395,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Image 1</span></span></span></p>"
        },
        {
          "id": 40396,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Image 4</span></span></span></p>"
        },
        {
          "id": 40397,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Image 3</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endoscopic and barium swallow images of a lesion in the esophagus of a patient are as shown below. What is the expected histopathological finding?</span></span> (AIIMS MAY 2017)</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/36.jpg\" style=\"height:251px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/37.jpg\" style=\"height:417px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/38.jpg\" style=\"height:281px; width:400px\" /></span></span></span></p>",
      "unique_key": "Q5610336",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064519,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Image 3 </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The shows an esophageal exophytic growth on endoscopy. <strong>Barium swallow reveals an</strong> <strong>apple core appearance in the middle 1/3 of the esophagus suggestive of squamous cell carcinoma</strong>. The characteristic histopathological finding in this condition are nests of stratified malignant cells and keratin pearls, which are noted in image 3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In contrast to adenocarcinoma, half of squamous cell carcinomas occur in the middle third of the esophagus. Squamous cell carcinoma begins as an in-situ lesion termed squamous dysplasia (this lesion is referred to as intraepithelial neoplasia or carcinoma in situ at other sites). Early lesions appear as small, gray-white, plaque-like thickenings. Over months to years, they grow into tumor masses that may be polypoid or exophytic and protrude into and obstruct the lumen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-110450.png\" style=\"height:249px; width:600px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Squamous cell carcinoma of the esophagus typically occurs in the middle third of the esophagus and is characterized histologically by nests of stratified malignant cells and keratin pearls, as seen in Image 3.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotran Pathologic basis of disease 8th edition Pg 1472, 1473</span></strong></span></span></p>",
      "correct_choice_id": 40397,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59613,
      "choices": [
        {
          "id": 237765,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class I</span></span></span></p>"
        },
        {
          "id": 237766,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class II</span></span></span></p>"
        },
        {
          "id": 237767,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class III</span></span></span></p>"
        },
        {
          "id": 237768,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Class IV</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 47-year-old woman with a history of obstructive sleep apnea is scheduled for elective surgery. During the preoperative assessment, the anesthesiologist performs an airway evaluation using the Mallampati classification system. The patient is asked to open her mouth and protrude her tongue without phonating. Based on the visualization of the oral structures, the anesthesiologist classifies her airway as shown in the image. What is the Mallampati classification of this patient?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/01/picture2.jpg\" style=\"height:373px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q7011950",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064520,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Class II</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Mallampati classification is a simple and widely used method to predict the difficulty of endotracheal intubation by assessing the visibility of the oropharyngeal structures. In a Mallampati class II airway, the soft palate and the base of the uvula are visible when the patient opens their mouth and protrudes their tongue. This classification suggests a relatively straightforward intubation but indicates that the airway may still pose some challenges. The image provided in the scenario shows the features characteristic of Mallampati class II, making it the correct classification.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Class I</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: In a Mallampati class I airway, the hard palate, soft palate, entire uvula, and tonsillar pillars are visible. This represents the easiest airway to intubate, with no expected difficulty in visualizing the glottis during intubation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Class III</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A Mallampati class III airway is characterized by the visibility of only the soft palate and the base of the tongue, with the uvula either partially visible or not visible at all. This classification indicates a potentially more difficult intubation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Class IV</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: In Mallampati class IV, only the hard palate is visible, with neither the soft palate nor the uvula visible. This suggests a significantly more challenging airway, often requiring advanced airway management techniques.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Mallampati classification is a valuable tool for predicting the ease of intubation based on the visibility of the oropharyngeal structures. A Class II classification, where the soft palate and the base of the uvula are visible, suggests a moderately easy intubation, but with some potential for difficulty. Understanding this classification helps in planning for airway management during anesthesia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/01/picture3.jpg\" style=\"height:251px; width:600px\" /></span></span></span></p>",
      "correct_choice_id": 237766,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5291,
      "choices": [
        {
          "id": 21136,
          "text": "<p><span style=\"font-size:16px;\">Malleus</span></p>"
        },
        {
          "id": 21137,
          "text": "<p><span style=\"font-size:16px;\">Incus</span></p>"
        },
        {
          "id": 21138,
          "text": "<p><span style=\"font-size:16px;\">Stapes</span></p>"
        },
        {
          "id": 21139,
          "text": "<p><span style=\"font-size:16px;\">Vomer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Identify the structure given in the image: (NEET PG 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/image-1.jpg\" alt=\"\" width=\"300\" height=\"329\"></span></p>",
      "unique_key": "Q7734266",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064521,
      "difficulty_level": "beginner",
      "subjects_id": [
        9
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Incus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The structure given in the image is the incus.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The malleus has head, neck, handle (manubrium), a lateral and an anterior process. Head and neck of malleus lie in the attic. Manubrium is embedded in the fibrous layer of the tympanic membrane. The lateral process forms a knob-like projection on the outer surface of the tympanic membrane and gives attachment to the anterior and posterior malleolar folds.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The incus has a body and a short process, both of which lie in the attic, and a long process which hangs vertically and attaches to the head of stapes.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The stapes has a head, neck, anterior and posterior crura, and a footplate. The footplate is held in the oval window by annular ligament.</span></p><p><br><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. The malleus is the</strong> largest ossicle and is shaped like a mallet. The parts of the malleus are the head, neck, handle (manubrium), and anterior and lateral processes. The head and neck lie in the attic.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The tympanic membrane is connected to the handle of the malleus.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. The stapes</strong> has a head, neck, footplate, and anterior and posterior crura. The annular ligament holds the footplate of stapes in the oval window.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/01/12.jpg\" alt=\"\" width=\"700\" height=\"535\"></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The joints between the ear ossicles are synovial joints. A saddle-shaped joint is present between the incus and malleus. Incus and stapes articulate via a ball and socket joint.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Options D. Vomer&nbsp;</strong>A facial bone forming part of the nasal septum, unrelated to the middle ear.</span></p><p><img class=\"image_resized\" style=\"aspect-ratio:805/720;width:49.04%;\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/New%20Microsoft%20PowerPoint%20Presentation%20(2)_hruyO3L.jpg\" width=\"805\" height=\"720\"></p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The incus is one of the three auditory ossicles in the middle ear. It plays a critical role in hearing by transmitting sound vibrations from the malleus to the stapes.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 9</strong></span></p>",
      "correct_choice_id": 21137,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5595,
      "choices": [
        {
          "id": 22352,
          "text": "<p><span style=\"font-size:12.0pt;\">Aerobic culture of stool</span></p>"
        },
        {
          "id": 22353,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamate dehydrogenase and toxin assay</span></p>"
        },
        {
          "id": 22354,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamate dehydrogenase assay</span></p>"
        },
        {
          "id": 22355,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is considered to be the best for the detection of Clostridium difficile?</span><span style=\"font-size:10.5pt;\">&nbsp;(NEET PG 2022)</span></p>",
      "unique_key": "Q9173419",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064522,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Glutamate dehydrogenase and toxin assay</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A combination of glutamate dehydrogenase and toxin assay can be used for the detection of Clostridium difficile.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clostridium difficile is a gram-positive anaerobic bacillus that causes Clostridioides (formerly Clostridium) difficile infection after ingestion of spores of the organism. The more severe form of the condition is known as pseudomembranous colitis (PMC). Enzyme immunoassay to detect glutamate dehydrogenase is less specific compared to toxin detection for diagnosis. So a combination of the two can be used for diagnostic confirmation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The condition is most commonly <strong>associated with prolonged antimicrobial use</strong>, which interferes with the commensal colonic microflora. The <i><strong>most commonly implicated antibiotics are</strong></i> <i><strong>cephalosporins, ampicillin, and clindamycin</strong></i>. The spores are spread by contact with the feces of affected individuals or asymptomatic carriers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The spores germinate in the small intestine and produce two toxins-toxin A (enterotoxin) and toxin B (cytotoxin). These interfere with the epithelial-cell barrier function and result in diarrhea and pseudomembrane formation. The pseudomembranes appear as small whitish-yellow plagues initially which later coalesce to involve the entire colon wall. It contains necrotic leukocytes, fibrin, and cellular debris. The anamnestic IgG response determines which patients develop the disease or remain asymptomatic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Symptoms include diarrhea, fever, and abdominal pain. <strong>The diagnosis is based on a combination of clinical criteria and detection of toxin or the organism in stool samples. </strong>This can be done by <u>nucleic acid amplification testing (NAAT) methods such as polymerase chain reaction (PC) or by culture.</u></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Discontinuation of any ongoing antimicrobials and adequate hydration are general measures that are recommended. Oral fidaxomicin or vancomycin is the first-line treatment. Oral metronidazole can be used when these are not available.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aerobic culture of stool:&nbsp;</strong><i>C. difficile</i> is an anaerobic bacterium, making aerobic culture inappropriate and ineffective for its cultivation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Glutamate dehydrogenase assay alone:</strong> While sensitive, it lacks specificity for the detection of toxin-producing strains.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. None of the above:</strong> There are effective methods, particularly the one described in option B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For effective and accurate diagnosis of <i>Clostridioides difficile</i> infection, a combination of glutamate dehydrogenase and toxin assays is recommended. This approach ensures both the presence of the organism and its potential to cause disease through toxin production are assessed, guiding appropriate treatment and infection control measures.</span></p>",
      "correct_choice_id": 22353,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "InvestigationBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14443,
      "choices": [
        {
          "id": 57733,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Jaw Tumor</span></p>"
        },
        {
          "id": 57734,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿</span><span style=\"color:black;font-size:12pt;\">Dermoid cyst</span></p>"
        },
        {
          "id": 57735,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿</span><span style=\"color:black;font-size:12pt;\">Pleomorphic adenoma</span></p>"
        },
        {
          "id": 57736,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿</span><span style=\"color:black;font-size:12pt;\">Sebaceous cyst</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">A patient presents with a slowly progressive swelling that has been noticeable for the past 18 months. The swelling exhibits variable consistency, with some areas feeling hard and others feeling soft, image of patient is shown below. What is the likely diagnosis for this clinical presentation? (NEET PG 2019)</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/06/ns3.jpg\" alt=\"\" width=\"200\" height=\"299\"></span></p>",
      "unique_key": "Q4990538",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064523,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"color:black;font-size:12pt;\"><strong>Ans. C. Pleomorphic adenoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The case scenario and image showing a swelling lifting the ear lobe are suggestive of a pleomorphic adenoma. Pleomorphic adenomas are the most common benign tumors of the salivary glands, with the parotid gland being the most frequent site. These tumors are encapsulated and exhibit a mixed cellular composition, leading to a variable consistency, which is reflected in their name \"pleomorphic.\" Clinically, they present as painless, slow-growing masses. The characteristic lift of the earlobe due to the swelling is a classic sign of a parotid gland tumor. Untreated pleomorphic adenomas may undergo malignant transformation, hence surgical excision is typically recommended.</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/25/histopathology_of_pleomorphic_adenoma.png\" alt=\"\" width=\"700\" height=\"461\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Jaw Tumor:&nbsp;</strong>Jaw tumors, particularly those of the mandible or maxilla, are often bony growths or related to the teeth (odontogenic tumors). While they can cause facial asymmetry, they are usually centered around the bones and are not typically located in the parotid gland region. These tumors tend to be hard and lack the variable consistency described in the clinical presentation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Dermoid cyst:&nbsp;</strong>Dermoid cysts are benign cystic tumors containing skin appendages (such as hair follicles), and sometimes hair, teeth, or sebum. They are typically congenital and found on the face, neck, or ovary. While they can appear on the face or neck, the described clinical presentation is less suggestive of a dermoid cyst compared to a pleomorphic adenoma. Dermoid cysts often show indentation due to putty material.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Sebaceous cyst:&nbsp;</strong>Also known as an epidermal cyst, a sebaceous cyst is a benign growth arising from blocked sebaceous glands, often containing a thick, cheese-like material. Sebaceous cysts can appear almost anywhere on the body where sebaceous glands are found, including the face, and often show a black punctum. However, the described clinical presentation and duration better match a pleomorphic adenoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Pleomorphic adenoma is the most common benign tumor of the salivary glands, typically presenting as a painless, slow-growing mass with variable consistency and often lifting the earlobe due to its location in the parotid gland.</span></p>",
      "correct_choice_id": 57735,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56215,
      "choices": [
        {
          "id": 224277,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Retrolentiform</span></span></p>"
        },
        {
          "id": 224278,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sublentiform</span></span></p>"
        },
        {
          "id": 224279,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anterior limb</span></span></p>"
        },
        {
          "id": 224280,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Posterior limb</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old male patient presented with left-sided hemiparesis. Damage to which part of the internal capsule leads to this presentation?</span></span><span style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">INICET MAY 2022)</span></span></p>",
      "unique_key": "Q1586147",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064524,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Posterior limb</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The internal capsule is a white matter structure in the brain that contains many important tracts, including those for motor and sensory functions. Damage to specific parts of the internal capsule can result in different clinical presentations based on the fibers that are affected.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Posterior limb</span></strong><span style=\"font-size:12.0pt\"> is the part of the internal capsule that carries corticospinal and corticobulbar tracts, which are responsible for motor and sensory functions. Damage to the posterior limb can result in contralateral hemiparesis (weakness on the opposite side of the body). Therefore, a lesion in the posterior limb of the right internal capsule would lead to left-sided hemiparesis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Retrolentiform</span></strong><span style=\"font-size:12.0pt\">: This part of the internal capsule contains optic radiations, which are involved in visual processing. Damage here would lead to <strong>visual deficits</strong> rather than motor or sensory deficits.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Sublentiform</span></strong><span style=\"font-size:12.0pt\">: This part carries auditory radiations and is involved in hearing. Damage to this part would result in <strong>auditory deficits,</strong> not motor weakness.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Anterior limb</span></strong><span style=\"font-size:12.0pt\">: This part of the internal capsule contains frontopontine fibers and thalamocortical radiations, which are involved in <strong>cognitive and executive functions</strong>. Damage here might affect cognition but not typically result in hemiparesis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Damage to the posterior limb of the internal capsule can lead to contralateral hemiparesis due to the involvement of motor and sensory pathways.</span></span></span></p>",
      "correct_choice_id": 224280,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11142,
      "choices": [
        {
          "id": 44534,
          "text": "<p><span style=\"font-size:18px;\">Screening of family members</span></p>"
        },
        {
          "id": 44535,
          "text": "<p><span style=\"font-size:18px;\">Mobilization of resources</span></p>"
        },
        {
          "id": 44536,
          "text": "<p><span style=\"font-size:18px;\">Social support</span></p>"
        },
        {
          "id": 44537,
          "text": "<p><span style=\"font-size:18px;\">Interpersonal therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\"><strong>Which of the following elements is not included in the provisions of the Mental Health Care Act of 2017, as per the WHO's mhGAP? </strong><i><strong>[AIIMS NOV 2018]</strong></i></span></p>",
      "unique_key": "Q2335178",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064525,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. (a) Screening of family members</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">The Mental Health Care Act, 2017 focuses on the rights and treatment of patients with mental illness, but it does not specifically include provisions for the screening of family members.</span></li><li><span style=\"font-size:18px;\">The Act covers various aspects such as the capacity to make healthcare decisions, advance directives, nominated representatives, types of admissions, bans on certain treatments (like direct ECT for minors and psychosurgery), decriminalization of suicide attempts, and regulations on restraints and seclusion.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Mobilization of resources:</strong> The Act includes provisions related to the mobilization of resources for mental health services.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. Social support:</strong> Social support is a crucial aspect of mental health care covered under the Act, ensuring that patients receive necessary support from family and community.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option D. Interpersonal therapy:</strong> While specific therapies may not be explicitly listed, the Act does promote access to various mental health treatments, which can include interpersonal therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Screening of family members is not included in the Mental Health Care Act, 2017.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>MENTAL HEALTHCARE ACT, 2017 (MHCA 2017)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Deals with rights of patients with mental illness and treatment delivery. Important clauses-</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">A. Capacity to make mental healthcare and treatment decision- Every person, including patients with mental illness, are assumed to have it if they can-</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Can understand the information provided to them</span></li><li><span style=\"font-size:18px;\">Understand the consequences of their decisions</span></li><li><span style=\"font-size:18px;\">Can communicate their decision</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">B. Advance directive- Every person (not a minor) can make an advance directive in which he can mention-</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">How they wish to be treated/not treated for a mental illness</span></li><li><span style=\"font-size:18px;\">Applicable only if a person loses the capacity to take mental healthcare or treatment decisions</span></li><li><span style=\"font-size:18px;\">Duty of psychiatrist (or medical officer) to give treatment according to the advance directive</span></li><li><span style=\"font-size:18px;\">Doctor is not liable in case of unforeseen consequences while following the advance directive</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">C. Nominated representative (NR)-</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Every person can appoint a nominated representative</span></li><li><span style=\"font-size:18px;\">In case of loss of capacity to make mental healthcare and treatment decision, NR would help in taking decisions about treatment</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">D. Admission- MHCA 2017 allows two types of admissions</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">Independent admissions- When the patient himself wants to get admitted</span></li><li><span style=\"font-size:18px;\">Supported admission (for a maximum of 30 days)- A person who has lost the capacity to make mental healthcare or treatment decisions and requires significant support from a nominated representative can be admitted under a “supported admission”</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">E. Ban on direct ECT</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">F. Ban on ECT for minors</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">G. Ban on psychosurgery</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">H. Decriminalisation of suicide attempt - Any person who attempts suicide shall be presumed to be under severe stress and should not be tried or punished</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">I. Restraints and seclusions - A patient can be physically restrained only-</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\">If it is the only way to prevent harm to self or others</span></li><li><span style=\"font-size:18px;\">If authorised by a psychiatrist in charge</span></li></ul>",
      "correct_choice_id": 44534,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13153,
      "choices": [
        {
          "id": 52573,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 52574,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 52575,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 52576,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman presented with total ophthalmoplegia, pulsatile proptosis of the right eye, retroorbital pain accompanied with fever and headache. On examination, fundus and BP were normal. Which of the following structures are involved?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Abducens nerve</span></li><li><span style=\"font-size:12.0pt;\">Oculomotor nerve</span></li><li><span style=\"font-size:12.0pt;\">Internal carotid artery</span></li><li><span style=\"font-size:12.0pt;\">Cavernous sinus</span></li></ol>",
      "unique_key": "Q1784562",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064526,
      "difficulty_level": "intermediate",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 2, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The clinical presentation of pulsatile proptosis, retroorbital pain, fever, and headache in a pregnant woman suggests the involvement of multiple cranial structures, primarily those associated with the cavernous sinus, a critical venous sinus at the base of the brain that acts as a conduit for venous blood drainage from the brain and eye. This constellation of symptoms and signs is indicative of cavernous sinus thrombosis (CST), a severe and potentially life-threatening condition.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Cavernous sinus thrombosis (CST) is a septic thrombus formed in the cavernous sinus due to the spread of infection from sinuses, teeth, ears, nose, and skin of the face.</span></li><li><span style=\"font-size:12.0pt;\">Symptoms include fever, severe headache, supraorbital pain, seizures, and edema in the mastoid region.</span></li><li><span style=\"font-size:12.0pt;\">Eye signs include proptosis, chemosis, and diplopia due to ophthalmoplegia from the involvement of oculomotor (CN-III), trochlear (CN-IV), and abducens nerve (CN-VI).</span></li><li><span style=\"font-size:12.0pt;\">Absence of corneal sensation due to the involvement of the ophthalmic division of trigeminal nerve (CN-V1)</span></li><li><span style=\"font-size:12.0pt;\">Ipsilateral ptosis, dilated pupil, and absence of direct and consensual pupillary right reflex due to oculomotor nerve palsy.</span></li><li><span style=\"font-size:12.0pt;\">Pulsatile proptosis occurs with the involvement of the internal carotid artery.</span></li><li><span style=\"font-size:12.0pt;\">Brain magnetic resonance imaging or magnetic resonance venography should be done urgently for diagnosis.</span></li><li><span style=\"font-size:12.0pt;\">Management of CST includes intravenous broad-spectrum antibiotics, analgesics, anti-inflammatory drugs, and anticoagulants.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/inicet-ophtha-15.jpg\" alt=\"\" width=\"500\" height=\"439\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/24/picture89.jpg\" alt=\"\" width=\"1000\" height=\"289\"></p>",
      "correct_choice_id": 52576,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6508,
      "choices": [
        {
          "id": 26001,
          "text": "<p><span style=\"font-size:12.0pt;\">Tablet alprazolam 0.5 mg once a day before bedtime for 7 days</span></p>"
        },
        {
          "id": 26002,
          "text": "<p><span style=\"font-size:12.0pt;\">Tablet alprazolam 0.5 mg HS for 7 days</span></p>"
        },
        {
          "id": 26003,
          "text": "<p><span style=\"font-size:12.0pt;\">Tablet alprazolam 500 mcg one tablet OD for 7 days</span></p>"
        },
        {
          "id": 26004,
          "text": "<p><span style=\"font-size:12.0pt;\">Tablet alprazolam ½ mg tablet HS daily</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">As an Indian medical intern, which of the following is the correct format for prescription of alprazolam? (NEET PG 2021)</span></p>",
      "unique_key": "Q8135015",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064527,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Tablet alprazolam 0.5 mg once a day before bedtime for 7 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>IMPORTANT POINTS REGARDING PRESCRIPTION WRITING:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Prescription is invalid without date and signature of the doctor.</span></li><li><span style=\"font-size:12.0pt;\">Drug name should never been written in abbreviation form (e.g. never write PCM for paracetamol).</span></li><li><span style=\"font-size:12.0pt;\">Abbreviations like OD, BD, HS etc should not be used in prescription.</span></li><li><span style=\"font-size:12.0pt;\">Leading zeros should always be mentioned (e.g. 0.5 mg is correct but .5 mg is incorrect)</span></li><li><span style=\"font-size:12.0pt;\">Trail zeros should never be written (e.g. 5 mg is correct but 5.0 is incorrect).</span></li><li><span style=\"font-size:12.0pt;\">Microgram should be written as mcg not as µg.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When writing a prescription, always avoid abbreviations for dosage instructions, use clear and complete language, include leading zeros for dosages less than one, and avoid trailing zeros. The correct format ensures clarity and safety for the patient.</span></p>",
      "correct_choice_id": 26001,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 1031,
      "choices": [
        {
          "id": 4120,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Block sodium channels</span></span></span></p>"
        },
        {
          "id": 4121,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Block potassium channels</span></span></span></p>"
        },
        {
          "id": 4122,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Block calcium channels</span></span></span></p>"
        },
        {
          "id": 4123,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Block chloride channels</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the mechanism of action of local anesthetics?</span></span></span></p>",
      "unique_key": "Q6214791",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064528,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Block sodium channels </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mechanism:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Local anesthetics primarily act by blocking the sodium channels bound to the membrane of the nerve, thus inhibiting sodium influx into the nerve and avoiding depolarization of the nerve.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">States of Sodium Channels:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> The voltage-gated sodium channels exist in three states:</span></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Resting (non-conducting)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Open (conducting)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inactivated (non-conducting)</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Affinity:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Local anesthetics have maximum affinity for the sodium channels in the inactivated state.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Block potassium channels:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blocking potassium channels is not the primary mechanism of action for local anesthetics. Potassium channels are more involved in the repolarization phase of the action potential.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Block calcium channels:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blocking calcium channels is not the primary mechanism of action for local anesthetics. Calcium channels are more involved in neurotransmitter release at synapses.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Block chloride channels:</span></strong></span></span></p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Blocking chloride channels is not the primary mechanism of action for local anesthetics. Chloride channels are typically associated with inhibitory neurotransmission.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Local anesthetics work by blocking voltage-gated sodium channels, which prevents the influx of sodium ions into nerve cells, thereby inhibiting nerve depolarization and the propagation of action potentials.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Miller&rsquo;s Anesthesia, 9th Ed. Pg 871</span></strong></span></span></p>",
      "correct_choice_id": 4120,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4097,
      "choices": [
        {
          "id": 16367,
          "text": "<p><span style=\"font-size:12.0pt;\">A-4, B-3, C-2, D-1</span></p>"
        },
        {
          "id": 16368,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-3, C-2, D-4</span></p>"
        },
        {
          "id": 16369,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-2, C-3, D-4</span></p>"
        },
        {
          "id": 16370,
          "text": "<p><span style=\"font-size:12.0pt;\">A-4, B-2, C-3, D-1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following E. coli with their respective pathogenesis? (INICET NOV 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/02/screenshot-2024-07-02-155807.png\" alt=\"\" width=\"700\" height=\"177\"></span></p>",
      "unique_key": "Q9162947",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064529,
      "difficulty_level": "beginner",
      "subjects_id": [
        6
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) A-1, B-2, C-3, D-4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The correctly matched pairs are as follows:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. <strong>ETEC (Enterotoxigenic E. coli)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Mechanism:</strong> Produces a heat-stable toxin and causes activation of guanylyl cyclase.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Match:</strong> A. Produces a heat-stable toxin and causes activation of guanylyl cyclase.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2. <strong>EIEC (Enteroinvasive E. coli)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Mechanism:</strong> Invades intestinal mucosal cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Match:</strong> B. Invades intestinal mucosal cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">3. <strong>EHEC (Enterohemorrhagic E. coli)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Mechanism:</strong> Produces a toxin against endothelial cells.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Match:</strong> C. Produces a toxin against endothelial cells.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. EPEC (Enteropathogenic E. coli)</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Mechanism:</strong> Adheres to the mucosal surface and causes effacement of microvilli.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Match:</strong> D. Adheres to the mucosal surface and causes effacement of microvilli.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/02/screenshot-2024-07-02-160222.png\" alt=\"\" width=\"1000\" height=\"637\"></strong></span></p>",
      "correct_choice_id": 16369,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 59614,
      "choices": [
        {
          "id": 237769,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Direct stimulation of acetylcholine receptors</span></span></span></p>"
        },
        {
          "id": 237770,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inhibition of acetylcholinesterase at the synaptic cleft</span></span></span></p>"
        },
        {
          "id": 237771,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Competitive inhibition of acetylcholine receptors at the neuromuscular junction</span></span></span></p>"
        },
        {
          "id": 237772,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Activation of calcium channels in the sarcoplasmic reticulum</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 70-year-old man with a history of chronic obstructive pulmonary disease (COPD) is undergoing an elective hip replacement surgery. During anesthesia induction, a non-depolarizing muscle relaxant is administered to facilitate intubation and surgical access. Shortly after administration, the patient develops profound muscle relaxation and paralysis without any muscle fasciculations. Which of the following best describes the mechanism of action of the muscle relaxant used in this scenario?</span></span></span></p>",
      "unique_key": "Q5062024",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064530,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Correct Answer: </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Competitive inhibition of acetylcholine receptors at the neuromuscular junction</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Curare group muscle relaxants, such as atracurium and rocuronium, are non-depolarizing neuromuscular blocking agents. These drugs work by competitively binding to acetylcholine (ACh) receptors at the neuromuscular junction without activating them, thereby preventing acetylcholine from binding to these receptors. This inhibition blocks the action of acetylcholine, leading to muscle paralysis and relaxation. Since these agents do not depolarize the muscle membrane, they do not cause initial muscle contractions (fasciculations), making them useful during surgeries requiring controlled muscle relaxation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Direct stimulation of acetylcholine receptors</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This mechanism describes the action of depolarizing neuromuscular blocking agents like succinylcholine, which initially cause muscle contractions before leading to paralysis. This is not the mechanism of curare group drugs, which are non-depolarizing.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Inhibition of acetylcholinesterase at the synaptic cleft</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Inhibiting acetylcholinesterase increases acetylcholine levels at the neuromuscular junction, enhancing muscle contraction, which is the opposite of muscle relaxation. This action is seen with agents like neostigmine, used to reverse neuromuscular blockade.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Activation of calcium channels in the sarcoplasmic reticulum</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This action describes drugs like dantrolene, which is used to treat malignant hyperthermia by inhibiting calcium release from the sarcoplasmic reticulum, thus preventing muscle contraction. It does not describe the mechanism of curare-like drugs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Curare group muscle relaxants are non-depolarizing agents that competitively inhibit acetylcholine receptors at the neuromuscular junction, preventing acetylcholine binding and resulting in muscle paralysis without initial contractions. This mechanism is crucial for inducing controlled muscle relaxation during surgical procedures.</span></span></span></p>",
      "correct_choice_id": 237771,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15613,
      "choices": [
        {
          "id": 62412,
          "text": "<p><span style=\"font-size:12.0pt;\">Bisphosphonates</span></p>"
        },
        {
          "id": 62413,
          "text": "<p><span style=\"font-size:12.0pt;\">Raloxifene</span></p>"
        },
        {
          "id": 62414,
          "text": "<p><span style=\"font-size:12.0pt;\">Estrogen</span></p>"
        },
        {
          "id": 62415,
          "text": "<p><span style=\"font-size:12.0pt;\">Combined OC pills</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which drug is used as a first line management for postmenopausal female with osteoporosis?(NEET PG 2020)</span></p>",
      "unique_key": "Q3901392",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064731,
      "difficulty_level": "beginner",
      "subjects_id": [
        15
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Bisphosphonates</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>OSTEOPOROSIS</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Osteoporosis is&nbsp;<strong>reduction in bone mass (density)</strong> i.e., there is <strong>quantitative decrease of units of bone formation</strong> but each unit has qualitatively normal configuration.</span></li><li><span style=\"font-size:12.0pt;\">So, osteoporosis characteristically has <strong>normal calcium, phosphate and alkaline phosphatase levels</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Bone Mineral Density is measured by DEXA (Dual Emission X-ray Absorptiometry) Scan and it is matched to DEXA scan of 30-year-old individual of the same sex and T score is calculated.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/16/untitled-1314_QtIykjg.jpg\" alt=\"\" width=\"900\" height=\"256\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Etiology:</strong></span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/03/screenshot-2024-01-02-192803_FRPtofW.jpg\" alt=\"\" width=\"1000\" height=\"365\"></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Imaging:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Radiological features are <strong>loss of vertical height of vertebrae</strong> (collapse) and <strong>codfish appearance </strong>(concave superior and inferior surfaces) of vertebrae.</span></li></ul></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/03/17.jpg\" alt=\"\" width=\"250\" height=\"312\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Codfish vertebrae</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Singh’s Index</strong> is used for osteoporosis grading.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment:&nbsp;</strong>Drugs used in osteoporosis are:</span><ol><li><span style=\"font-size:12.0pt;\"><strong>Inhibit resorption:&nbsp;</strong>Bisphosphonates (drug of choice), Denosumab, calcitonin, estrogen, SERMS, gallium nitrate.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Stimulate formation:&nbsp;</strong>Teriparatide (PTH analogue), calcium, calcitriol, fluorides.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Both actions:&nbsp;</strong>Strontium ranelate</span><br>&nbsp;</li></ol></li><li><span style=\"font-size:12.0pt;\"><strong>Bisphosphonases&nbsp;</strong>(pyrophosphate analogs) bind to the surface of hydroxyapatite crystals and inhibits resorption.</span></li><li><span style=\"font-size:12.0pt;\">These drugs are not metabolized and are excreted intact in urine.</span></li><li><span style=\"font-size:12.0pt;\">Their t 1/2 is 1-10 years and <strong>cessation of treatment does not lead to rapid bone loss </strong>(as occurs with estrogen replacement therapy).</span></li><li><span style=\"font-size:12.0pt;\">These drugs decrease the incidence of vertebral and non-vertebral fractures.</span></li><li><span style=\"font-size:12.0pt;\">These are the drugs of choice in postmenopausal osteoporotic females.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Raloxifene</strong>. Selective estrogen receptor modulator (SERM) act as estrogen antagonist in breast tissue and as an agonist in bone. Raloxifene selectively stimulates estrogen receptor in bone and is used in treatment of osteoporosis. It reduces risk of breast cancer also.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Estrogen</strong>. Hormone replacement therapy is the mainstay of bone loss prevention in postmenopausal osteoporosis with estrogen treatment. Daily dose of 0.625 mg of conjugated estrogen in combination with progestins are recommended. Progestin is essential (even though it has no independent effect on bone) to reduce the risk of developing endometrial cancer (due to estrogen).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Combined OC pills</strong>. Combination oral contraceptives (COCs) alleviate climacteric symptoms and might have a positive effect on BMD. Of note, progestin is the dominant component over estrogen in COCs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Bisphosphonates are the first line drugs or drugs of choice to treat osteoporosis in post-menopausal females.</span></li></ul>",
      "correct_choice_id": 62412,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 52808,
      "choices": [
        {
          "id": 210721,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acute interstitial nephritis</span></span></span></p>"
        },
        {
          "id": 210722,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Poststreptococcal glomerulonephritis</span></span></span></p>"
        },
        {
          "id": 210723,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis</span></span></span></p>"
        },
        {
          "id": 210724,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IgA nephropathy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A woman presents to you with fever, arthralgia, ulcers, fatigue for the past six months, and new-onset hematuria. Urine examination reveals RBC casts and proteinuria. What is the likely diagnosis? (NEET PG 2023)</span></span></span></p>",
      "unique_key": "Q3984765",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064732,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><strong><span style=\"font-size:12.0pt\">C. Lupus nephritis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis is a common complication of systemic lupus erythematosus (SLE), an autoimmune disease that can affect multiple organ systems. The patient&#39;s symptoms of fever, arthralgia, ulcers, and fatigue, combined with new-onset hematuria and findings of RBC casts and proteinuria in the urine, are indicative of systemic involvement typical of lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Lupus nephritis is characterized by inflammation of the kidneys, often leading to hematuria, proteinuria, and renal impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Next Step -</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Conducting an ANA (antinuclear antibody) test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Performing an anti-dsDNA (anti-double stranded DNA) test, which is noted as being very specific and correlates with lupus nephritis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A. Acute interstitial nephritis:</span></strong><span style=\"font-size:12.0pt\"> This condition typically presents with WBC casts rather than RBC casts in the urine and is not usually associated with systemic symptoms like fever, arthralgia, or ulcers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. Poststreptococcal glomerulonephritis (PSGN):</span></strong><span style=\"font-size:12.0pt\"> While PSGN can cause RBC casts and proteinuria, it is generally a renal-limited condition and does not present with systemic symptoms like fever, arthralgia, and ulcers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D. IgA nephropathy:</span></strong><span style=\"font-size:12.0pt\"> IgA nephropathy is also a renal-limited condition and typically does not present with systemic symptoms. It is characterized by recurrent episodes of gross hematuria, usually following upper respiratory infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lupus nephritis should be suspected in patients with systemic lupus erythematosus who present with renal symptoms such as hematuria and proteinuria, especially when accompanied by systemic symptoms like fever, arthralgia, ulcers, and fatigue. Further testing, including ANA and anti-dsDNA antibodies, is warranted to confirm the diagnosis.</span></span></p>",
      "correct_choice_id": 210723,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54528,
      "choices": [
        {
          "id": 217581,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduced risk of colon cancer</span></p>"
        },
        {
          "id": 217582,
          "text": "<p><span style=\"font-size:12.0pt;\">Continuous involvement of the gut</span></p>"
        },
        {
          "id": 217583,
          "text": "<p><span style=\"font-size:12.0pt;\">Higher risk of perianal fistula</span></p>"
        },
        {
          "id": 217584,
          "text": "<p><span style=\"font-size:12.0pt;\">Rarely present with daily hematochezia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Crohn’s disease in comparison to ulcerative colitis is least likely to show which of the following?&nbsp;</span>&nbsp;(INICET MAY 2024)</p>",
      "unique_key": "Q4339584",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064733,
      "difficulty_level": "beginner",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;B) Continuous involvement of the gut</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Crohn's disease and ulcerative colitis are both types of inflammatory bowel diseases (IBD), but they have distinct pathological and clinical features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Key Features of Crohn's Disease:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Segmental involvement</strong>: Crohn's disease is characterized by patchy, segmental involvement of the gastrointestinal tract, known as \"skip lesions.\" This contrasts with ulcerative colitis, which typically involves continuous, uninterrupted inflammation of the colon.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Continuous Involvement of the Gut</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This feature is typical of ulcerative colitis, where the inflammation is continuous and starts from the rectum extending proximally in a continuous manner without skipping any areas. In Crohn's disease, the inflammation is discontinuous, with normal areas interspersed between inflamed regions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Reduced risk of colon cancer:</strong> This is true for Crohn's disease compared to ulcerative colitis, as the risk of progression to malignancy is generally lower, especially for non-colonic Crohn's.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Higher risk of perianal fistula:</strong> Crohn's disease has a higher risk of perianal complications, including fistulas, due to the transmural nature of its inflammation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rarely present with daily hematochezia:</strong> Daily hematochezia is less common in Crohn's disease compared to ulcerative colitis, which is more likely to cause continuous bloody diarrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Continuous involvement of the gut is least likely to be associated with Crohn's disease, which is characterized by segmental, patchy inflammation known as \"skip lesions.\"</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Key Differences Between Crohn’s Disease &amp; Ulcerative Colitis:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_DvElxjx.png\" width=\"1409\" height=\"446\"></span></p>",
      "correct_choice_id": 217582,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10117,
      "choices": [
        {
          "id": 40434,
          "text": "<p><span style=\"font-size:12.0pt;\">Peripheral smear</span></p>"
        },
        {
          "id": 40435,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelets</span></p>"
        },
        {
          "id": 40436,
          "text": "<p><span style=\"font-size:12.0pt;\">Hb concentration</span></p>"
        },
        {
          "id": 40437,
          "text": "<p><span style=\"font-size:12.0pt;\">Leucocytic count</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with bilateral proptosis. Which investigation will help you in arriving at a diagnosis of chloroma? </span>(AIIMS MAY 2017)</p>",
      "unique_key": "Q6995917",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064734,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Peripheral smear</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Chloroma or granulocytic sarcoma is an extramedullary manifestation of acute myeloid leukemia (AML</strong>). It is a localized tumor forming mass occurring in the skin or orbit due to local infiltration of the tissues by leukemic cells. The <strong>tumor is greenish in appearance due to the presence of myeloperoxidase.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The diagnosis of AML is made by a combination of routine blood picture and bone marrow examination, coupled with cytochemical stains and other special laboratory investigations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The best investigation among the given options would be a peripheral blood smear which shows the following-</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/45.jpg\" alt=\"\" width=\"500\" height=\"403\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Platelets:</strong> While platelet count can be abnormal in AML, it is not the primary diagnostic tool for chloroma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hb concentration:</strong> Hemoglobin concentration might be reduced in AML due to anemia, but it is not specific for diagnosing chloroma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Leucocytic count:</strong> Leukocyte count can be elevated, normal, or low in AML, but it does not specifically help diagnose chloroma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The peripheral blood smear is the key investigation to diagnose chloroma, revealing the presence of myeloblasts, which are indicative of acute myeloid leukemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cortan pathologic basis of disease, 8<sup>th</sup> edition, page no - 1154</strong></span></p>",
      "correct_choice_id": 40434,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6136,
      "choices": [
        {
          "id": 24513,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sertoli cell only syndrome</span></span></span></p>"
        },
        {
          "id": 24514,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Testicular atrophy</span></span></span></p>"
        },
        {
          "id": 24515,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Benign testicular neoplasm</span></span></span></p>"
        },
        {
          "id": 24516,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Orchitis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 25-year-old male patient is evaluated for primary infertility. Semen analysis shows azoospermia. A testicular biopsy is done and the image is shown below. The shown finding is consistent with?&nbsp;</span></span>(NEET PG 2022)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/picture9_PMXBtsB.jpg\" style=\"height:187px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q6985548",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064735,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Sertoli cell only syndrome </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sertoli cell only syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given clinical scenario and the biopsy findings are consistent with the diagnosis of Sertoli cell-only syndrome.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients with Sertoli cell-only syndrome typically present between the ages of 20 and 40 years with primary infertility.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diagnosis is confirmed through testicular biopsy.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The histopathology of the biopsy specimen typically shows seminiferous tubules populated by only Sertoli cells, with thickening of the tubular basement membrane and absence of germ cells, which is characteristic of Sertoli cell-only syndrome.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Testicular atrophy</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Testicular atrophy may present with decreased testicular volume and could be due to various causes like mumps orchitis, trauma, or varicocele. The histopathological findings would not specifically show the absence of germ cells with the presence of only Sertoli cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Benign testicular neoplasm</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Benign testicular neoplasms would present with a mass in the testis and would show specific neoplastic cells on histopathology rather than the absence of germ cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Orchitis</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Orchitis typically presents with inflammation, pain, and swelling of the testes, and the biopsy would show inflammatory infiltrates rather than the absence of germ cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sertoli cell-only syndrome is characterized by primary infertility and azoospermia, with testicular biopsy showing seminiferous tubules populated only by Sertoli cells and absence of germ cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910341/\" style=\"color:#0563c1; text-decoration:underline\"><strong>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7910341/</strong></a></span></span></span></p>",
      "correct_choice_id": 24513,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29280,
      "choices": [
        {
          "id": 117026,
          "text": "<p><span style=\"font-size:12.0pt;\">It is approved for treatment of absent seizures</span></p>"
        },
        {
          "id": 117027,
          "text": "<p><span style=\"font-size:12.0pt;\">Fine tremors can be noted within therapeutic range</span></p>"
        },
        {
          "id": 117028,
          "text": "<p><span style=\"font-size:12.0pt;\">It does not cause teratogenicity</span></p>"
        },
        {
          "id": 117029,
          "text": "<p><span style=\"font-size:12.0pt;\">It is not absorbed orally</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following statements regarding lithium is correct?&nbsp;(INICET MAY 2023)</span></p>",
      "unique_key": "Q9655753",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064736,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Fine tremors can be noted within therapeutic range</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lithium is a commonly used medication for the treatment of bipolar disorder, but it can cause fine tremors within the therapeutic range. The tremors are generally mild and not a significant side effect for most patients, but in some cases, they can be bothersome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. It is approved for treatment of absent seizures</strong>: This is incorrect. Lithium is not used for the treatment of absent seizures. It is primarily used in the management of bipolar disorder and sometimes for treatment-resistant depression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. It does not cause teratogenicity</strong>: This is incorrect. Lithium can cause teratogenic effects, particularly if used during the first trimester of pregnancy. It is associated with an increased risk of cardiac anomalies, such as Ebstein's anomaly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It is not absorbed orally</strong>: This is incorrect. Lithium is well absorbed orally and reaches peak plasma concentrations within a few hours of ingestion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lithium, a medication commonly used for bipolar disorder, can cause fine tremors within the therapeutic range. It is well absorbed orally and has teratogenic potential, making it important to use with caution in pregnant women.</span></p>",
      "correct_choice_id": 117027,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13780,
      "choices": [
        {
          "id": 55081,
          "text": "<p><span style=\"font-size:12.0pt;\">Temperature</span></p>"
        },
        {
          "id": 55082,
          "text": "<p><span style=\"font-size:12.0pt;\">Pain</span></p>"
        },
        {
          "id": 55083,
          "text": "<p><span style=\"font-size:12.0pt;\">Touch</span></p>"
        },
        {
          "id": 55084,
          "text": "<p><span style=\"font-size:12.0pt;\">Proprioception</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following sensations is not perceived by the spinal nucleus of the trigeminal nerve?</span></p>",
      "unique_key": "Q4623598",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064737,
      "difficulty_level": "beginner",
      "subjects_id": [
        3
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Proprioception</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Proprioception refers to the sense of the relative position of body parts and the strength of effort being employed in movement. It provides the brain with information about limb position, movement, and force. It is perceived by the mesencephalic nucleus of the trigeminal nerve, not the spinal nucleus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Temperature</strong>: Temperature sensation refers to the ability of the body to perceive differences in external and internal temperatures.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Relation to Spinal Nucleus of Trigeminal Nerve</strong>: The spinal nucleus of the trigeminal nerve plays a key role in mediating temperature sensations from the face. It receives input from the descending or spinal tract of the trigeminal nerve for temperature sensation from the face.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Pain</strong>: Pain is an unpleasant sensory and emotional experience associated with actual or potential tissue damage.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Relation to Spinal Nucleus of Trigeminal Nerve</strong>: The spinal nucleus is responsible for pain sensation from the face. Pain fibers from the face descend along the spinal tract of the trigeminal nerve and synapse in the spinal nucleus of the trigeminal nerve.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Touch</strong>: Touch or tactile sensation refers to the ability of the body to perceive pressure or contact with the skin.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Relation to Spinal Nucleus of Trigeminal Nerve</strong>: Light touch from the face is also processed by the spinal nucleus, but it's worth noting that discriminative touch (ability to recognize specific shapes and textures) from the face is primarily processed by the main or chief sensory nucleus of the trigeminal nerve, not the spinal nucleus.</span></li></ul><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:&nbsp;</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The trigeminal nerve consists of 4 nuclei:&nbsp;</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/ia-13.jpg\" alt=\"\" width=\"600\" height=\"233\"></p>",
      "correct_choice_id": 55084,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43277,
      "choices": [
        {
          "id": 172775,
          "text": "<p><span style=\"font-size:12.0pt;\">Axillary lymph node status</span></p>"
        },
        {
          "id": 172776,
          "text": "<p><span style=\"font-size:12.0pt;\">Size</span></p>"
        },
        {
          "id": 172777,
          "text": "<p><span style=\"font-size:12.0pt;\">Distant metastasis</span></p>"
        },
        {
          "id": 172778,
          "text": "<p><span style=\"font-size:12.0pt;\">Hormonal status</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Most important prognostic factor for Ca Breast is: (INICET Nov 2023)</span></p>",
      "unique_key": "Q5452663",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064738,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Axillary lymph node status</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Positive axillary lymph node involvement usually indicates a higher chance of recurrence and a poorer prognosis compared to no lymph node involvement. The number of affected lymph nodes also plays a crucial role in staging the cancer, which directly impacts treatment options and outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Size of the tumor:</strong> Generally, the larger the tumor, the worse the prognosis because a larger tumor size often correlates with a more advanced stage of cancer. Tumor size is considered when staging breast cancer, with larger tumors often requiring more aggressive treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Distant metastasis:</strong> The presence of distant metastases (stage IV breast cancer) generally indicates a much poorer prognosis because it suggests that the cancer is more aggressive and widespread.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hormonal status:</strong> The hormonal status of the tumor (estrogen receptor (ER) and progesterone receptor (PR) positive or negative) influences both the prognosis and the treatment options. Hormone receptor-positive tumors are often less aggressive and more likely to respond to hormone therapy compared to hormone receptor-negative tumors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While all these factors are important in assessing the prognosis of breast cancer, the status of the axillary lymph nodes is traditionally considered a key indicator due to its implications for the spread of the disease within the body and potential treatment strategies.&nbsp;</span></p>",
      "correct_choice_id": 172775,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14015,
      "choices": [
        {
          "id": 56021,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MRCP</span></span></span></p>"
        },
        {
          "id": 56022,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ERCP</span></span></span></p>"
        },
        {
          "id": 56023,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HIDA</span></span></span></p>"
        },
        {
          "id": 56024,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CECT</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old male patient with a history of gallstones underwent a laparoscopic cholecystectomy 2 days ago. He now presents with severe pain in the right upper quadrant that has been worsening since the surgery. On examination, a tender swelling is palpable in the same area. Further evaluation reveals a collection in the subhepatic space. Bile leak is suspected. Which diagnostic test would be most appropriate to confirm the presence of a bile leak in this patient?</span></span></p>",
      "unique_key": "Q7596225",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064739,
      "difficulty_level": "difficult",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) ERCP</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Endoscopic retrograde cholangiopancreatography (ERCP) is highly recommended in cases of suspected bile leaks following cholecystectomy due to its dual diagnostic and therapeutic capabilities. ERCP allows for direct visualization and intervention in the biliary tree, where any potential leaks from the cystic duct or common bile duct can be identified and managed immediately. It can also facilitate the removal of retained stones or placement of stents to seal leaks, offering a swift resolution to symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>MRCP:</strong> While MRCP is useful for visualizing the biliary tract non-invasively, it cannot provide therapeutic intervention and may not be as definitive in the acute setting of a suspected leak. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>HIDA:</strong> This scan is sensitive for detecting biliary leaks but lacks the capability for any therapeutic intervention. It is more appropriate for confirming the leak rather than managing it. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>CECT:</strong> A CT scan provides excellent anatomical details and can identify fluid collections but is less specific for biliary leaks compared to HIDA or as actionable as ERCP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The educational takeaway is the recognition of ERCP as the most suitable diagnostic and therapeutic tool for managing suspected bile leaks post-cholecystectomy, particularly when immediate correction is necessary.</span></span></span></p>",
      "correct_choice_id": 56022,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4491,
      "choices": [
        {
          "id": 17940,
          "text": "<p><span style=\"font-size:12pt;\">Oxygen saturation</span></p>"
        },
        {
          "id": 17941,
          "text": "<p><span style=\"font-size:12pt;\">Oxygen content of the blood</span></p>"
        },
        {
          "id": 17942,
          "text": "<p><span style=\"font-size:12pt;\">Partial pressure of oxygen</span></p>"
        },
        {
          "id": 17943,
          "text": "<p><span style=\"font-size:12pt;\">Amount of inspired oxygen</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is measured by the device shown in the given image?</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1_WaIgI6p.jpg\" alt=\"\" width=\"250\" height=\"259\"></span></p>",
      "unique_key": "Q5451532",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064740,
      "difficulty_level": "beginner",
      "subjects_id": [
        19
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Oxygen saturation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Oxygen saturation (often referred to as SpO2) is the percentage of oxygen-saturated hemoglobin relative to the total hemoglobin (unsaturated + saturated) in the blood.</span></li><li><span style=\"font-size:12pt;\">The device measures this by non-invasively detecting the color change in blood as it binds oxygen.</span></li><li><span style=\"font-size:12pt;\">The image displays a reading of \"98%\", which is consistent with an SpO2 reading. Thus, this option is correct.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Oxygen content of the blood:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This refers to the amount of oxygen bound to hemoglobin in the blood plus any oxygen dissolved directly in the blood.</span></li><li><span style=\"font-size:12pt;\">Pulse oximeters do not measure the total oxygen content of the blood. They only measure the percentage of oxygen-saturated hemoglobin.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Partial pressure of oxygen:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Partial pressure of oxygen (often referred to as PaO2) is the pressure exerted by oxygen in the blood. It's typically measured using an arterial blood gas analysis.</span></li><li><span style=\"font-size:12pt;\">Pulse oximeters do not measure PaO2.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Amount of inspired oxygen:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This refers to the concentration of oxygen that a person is inhaling, often given as a percentage or fraction (FiO2).</span></li><li><span style=\"font-size:12pt;\">Pulse oximeters do not measure the amount of inspired oxygen.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Pulse oximetry measures the oxygen saturation (SpO2) of hemoglobin in the blood using the principles of Beer Lambert’s law and plethysmography.</span></p>",
      "correct_choice_id": 17940,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7111,
      "choices": [
        {
          "id": 28412,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polyclonal antibody which acts against CD20</span></span></span></p>"
        },
        {
          "id": 28413,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Polyclonal antibody which acts against CD50</span></span></span></p>"
        },
        {
          "id": 28414,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monoclonal antibody which acts against CD20</span></span></span></p>"
        },
        {
          "id": 28415,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Monoclonal antibody which acts against CD50</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rituximab is a:</span></span></span></p>",
      "unique_key": "Q8319535",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064741,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Monoclonal antibody which acts against CD20</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The suffix Mab implicates that it is a monoclonal antibody. </span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rituximab is a monoclonal antibody against CD-20 which is expressed on the B-cells.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is used in the treatment of B-cell lymphoma, non-Hodgkin lymphoma, and chronic lymphocytic leukemia. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyclonal antibody which acts against CD20</span></strong>: Polyclonal antibodies are produced by multiple clones of B-cells and therefore recognize multiple epitopes. Rituximab is not a polyclonal antibody; it is a monoclonal antibody.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyclonal antibody which acts against CD50</span></strong>: This is incorrect because rituximab is not polyclonal and does not target CD50.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monoclonal antibody which acts against CD50</span></strong>: This is incorrect because rituximab targets CD20, not CD50.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rituximab is a monoclonal antibody that targets the CD20 antigen on B-cells, making it effective in treating B-cell lymphoma, non-Hodgkin lymphoma, and chronic lymphocytic leukemia. The specificity of rituximab for CD20 allows it to selectively destroy B-cells, providing therapeutic benefits in these conditions.</span></span></span></p>",
      "correct_choice_id": 28414,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14155,
      "choices": [
        {
          "id": 56581,
          "text": "<p><span style=\"font-size:12.0pt;\">Transurethral resection of the bladder tumour</span></p>"
        },
        {
          "id": 56582,
          "text": "<p><span style=\"font-size:12.0pt;\">Resection with ileal conduit</span></p>"
        },
        {
          "id": 56583,
          "text": "<p><span style=\"font-size:12.0pt;\">Partial cystectomy with bladder reconstruction</span></p>"
        },
        {
          "id": 56584,
          "text": "<p><span style=\"font-size:12.0pt;\">Neo-adjuvant chemotherapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An adult male patient in his 60s presented to the outpatient department with a complaint of haematuria. Upon examination, a 2x2 cm bladder mass was observed, which was diagnosed as a low-grade transitional cell carcinoma. What is the recommended course of action for this patient? (INICET NOV 2021)</span></p>",
      "unique_key": "Q8070083",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064742,
      "difficulty_level": "intermediate",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Transurethral resection of the bladder tumour</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For this patient diagnosed with bladder carcinoma, transurethral resection of bladder tumor (TURBT) is the most beneficial treatment option among the given choices. Based on the available evidence, there is no indication of muscle invasion or advanced cancer, suggesting that the most probable pathological stage is pTa - low grade non-muscle invasive cancer, for which TURBT followed by intravesical chemotherapy is the recommended treatment. TURBT is performed to pathologically stage the tumor and determine the appropriate course of treatment. Intravesical therapy using chemotherapy or immunotherapy is administered after TURBT to eradicate any residual cancer cells in the bladder lining, but it is not effective against cancers that have spread to muscle layers.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the correct answer. TURBT is a standard initial procedure for diagnosing and treating visible tumors, especially for low-grade, noninvasive disease. It involves removing the tumor from the bladder wall via the urethra. The stage of the bladder cancer can be determined by examining the sample removed during a TURBT, which aids in further treatment decisions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Resection with ileal conduit</strong>: This is a more invasive surgery typically used for muscle invasive bladder cancers (radical cystectomy). An ileal conduit is a urinary diversion technique where urine is redirected through a piece of the intestine and out to a stoma on the abdomen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Partial cystectomy with bladder reconstruction</strong>: This involves removing a part of the bladder affected by cancer. It's reserved for select patients where the tumor is localized and not near the urethral or ureteral openings. It might not be the first line of treatment for a 2x2 cm low-grade tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Neo-adjuvant chemotherapy</strong>: This refers to chemotherapy given before a primary treatment in advanced cancers. In the case of bladder cancer, neo-adjuvant chemotherapy might be used before a surgery to shrink the tumor size or improve outcomes. However, for a low-grade, small tumor, it is not typically the first line of treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Non-muscle invasive bladder tumors (pTa/pT1): TUR-BT + Intravesical chemotherapy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Muscle invasive (pT2/pT3 and some pT4): Radical cystectomy + Ileal conduit</strong></span></p>",
      "correct_choice_id": 56581,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30511,
      "choices": [
        {
          "id": 121922,
          "text": "<p><span style=\"font-size:12.0pt;\">Organophosphates</span></p>"
        },
        {
          "id": 121923,
          "text": "<p><span style=\"font-size:12.0pt;\">Belladonna</span></p>"
        },
        {
          "id": 121924,
          "text": "<p><span style=\"font-size:12.0pt;\">Morphine</span></p>"
        },
        {
          "id": 121925,
          "text": "<p><span style=\"font-size:12.0pt;\">Pilocarpine</span></p>"
        }
      ],
      "text": "<p><span style=\"color:#333333;font-size:12pt;\">All&nbsp;of the following can cause miosis except</span></p>",
      "unique_key": "Q8742298",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064743,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans. B. Belladonna</strong></span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\">Belladonna is plant (Atropa belladonna) from which atropine (Anticholinergic drug) is obtained. It causes mydriasis not miosis.</span></p><p>&nbsp;</p><h3><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></h3><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Organophosphates:&nbsp;</strong>Organophosphates cause miosis by inhibiting acetylcholinesterase, which increases acetylcholine levels, resulting in overstimulation of muscarinic receptors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Morphine:&nbsp;</strong>Morphine induces miosis by stimulating the parasympathetic nervous system through opioid receptors, leading to pupil constriction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Pilocarpine:&nbsp;</strong>Pilocarpine is a cholinergic drug that causes miosis by directly activating muscarinic receptors in the eye.</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Educational objective:</strong></span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Miosis or pin point pupil is caused by:-</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:#333333;font-size:12pt;\">Organophosphate poisoning</span></li><li><span style=\"color:#333333;font-size:12pt;\">Opioids like morphine</span></li><li><span style=\"color:#333333;font-size:12pt;\">Phenol poisoning</span></li><li><span style=\"color:#333333;font-size:12pt;\">Pontine hemorrhage</span></li><li><span style=\"color:#333333;font-size:12pt;\">Cholinergic drugs like pilocarpine</span></li></ul><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: KDT 8<sup>th</sup>/115,122,127,499</strong></span></p>",
      "correct_choice_id": 121923,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7168,
      "choices": [
        {
          "id": 28640,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nelfinavir</span></span></span></p>"
        },
        {
          "id": 28641,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emtricitabine</span></span></span></p>"
        },
        {
          "id": 28642,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Abacavir</span></span></span></p>"
        },
        {
          "id": 28643,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Zidovudine</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient who is a known case of HIV is started on combined active antiretroviral therapy (cART). After few months of treatment, he develops palmo-plantar hyperpigmentation. What is the most likely drug implicated in this scenario?</span></span></p>",
      "unique_key": "Q2888938",
      "question_audio": null,
      "question_video": null,
      "map_id": 13064744,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. Emtricitabine</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emtricitabine is an NRTI (Nucleoside Reverse Transcriptase Inhibitor) which can lead to hyperpigmentation of the palms and soles.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option A</strong>. Nelfinavir is a protease inhibitor. It can cause diarrhea or loose stools, dyslipidemia, lipodystrophy and hyperlipidemia.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option C</strong>. Abacavir is an NRTI that can lead to Steven Johnson Syndrome.</span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option D</strong>. Zidovudine is an NRTI that can cause nail hyperpigmentation, bone marrow suppression, myopathy, hepatotoxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emtricitabine, an NRTI used in the treatment of HIV, is known to cause palmo-plantar hyperpigmentation as a side effect. This differentiates it from other antiretroviral medications such as nelfinavir, abacavir, and zidovudine, which have different side effect profiles.</span></span></span></p>",
      "correct_choice_id": 28641,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5335,
      "choices": [
        {
          "id": 21312,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mannitol salt agar</span></span></span></p>"
        },
        {
          "id": 21313,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Xylose lysine deoxycholate agar</span></span></span></p>"
        },
        {
          "id": 21314,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sorbitol MacConkey agar</span></span></span></p>"
        },
        {
          "id": 21315,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">CLED medium</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following culture media is used to differentiate other E. coli species from E. coli O157: H7?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">NEET PG 2020)</span></span></p>",
      "unique_key": "Q9752417",
      "question_audio": null,
      "question_video": null,
      "map_id": 13241059,
      "difficulty_level": "intermediate",
      "subjects_id": [
        6
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Sorbitol MacConkey agar</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E.coli O157: H7 can be differentiated from other E.coli species using sorbitol MacConkey agar.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">There are more than 150 serotypes of Shiga toxin-producing E.Coli (STEC). Of these, 0157:7 is the most common type. Unlike most other E.Coli serotypes, <strong>the STEC 0157:H7 does not use sorbitol and produces clear colonies on the Sorbitol MacConkey agar.</strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">O157: H7 strains also are negative for -glucuronidase using the substrate 4-methylumbelliferyl-B-glucuronide test. More than 90 per cent of other E. coli tests positive with this substrate.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Mannitol salt agar:</span></strong><span style=\"font-size:12.0pt\"> This medium is primarily used for the isolation of Staphylococcus species because it contains high concentrations of salt, inhibiting most other bacteria.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Xylose lysine deoxycholate agar:</span></strong><span style=\"font-size:12.0pt\"> Used for the isolation of Salmonella and Shigella species, which are also important enteric pathogens.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. CLED (Cystine Lactose Electrolyte Deficient) medium:</span></strong><span style=\"font-size:12.0pt\"> Designed for urinary tract infections to inhibit the swarming of Proteus species and allow the differentiation of other urinary pathogens based on lactose fermentation.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sorbitol MacConkey agar is critical for distinguishing E. coli O157 from other E. coli strains due to its unique inability to ferment sorbitol, helping guide appropriate public health responses and treatment options during outbreaks of foodborne illness.</span></span></span></p>",
      "correct_choice_id": 21314,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}